mrn,Document Date,AE Extracted JSON
64f5309673cbf36a4298a56da2b87048,5/28/19,"```json
[]
```

### Explanation:
After reviewing the provided clinical note, there are no **new or worsening adverse events** documented that emerged after the start of treatment with M7824. All symptoms mentioned (e.g., depression, mood changes, poor appetite, insomnia, fatigue) are explicitly noted as baseline symptoms that have been present since the patient's initial diagnosis in 2017 or earlier. Therefore, no adverse events meet the criteria for extraction."
64f5309673cbf36a4298a56da2b87048,6/11/19,"```json
[
  {
    ""AE Term"": ""Pruritus (throat itching)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Cough (dry, intermittent)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Rash (red rash to mid chest area)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,6/25/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events reported during this visit. The patient explicitly denies experiencing any symptoms she reported post week #1 infusion and states she tolerated the week #3 infusion well. Additionally, the note confirms ""No new adverse events to report for this visit."" Therefore, the output is an empty JSON list."
64f5309673cbf36a4298a56da2b87048,7/9/19,"```json
[
  {
    ""AE Term"": ""Bleeding episodes"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Abdominal discomfort"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,7/23/19,"```json
[
  {
    ""AE Term"": ""Oral blood blister"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Mucositis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,8/6/19,"```json
[
  {
    ""AE Term"": ""Rash maculo-papular"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Decreased appetite"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Weight loss"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,8/20/19,"```json
[
  {
    ""AE Term"": ""Facial weakness (mapped to CTCAE term: Facial paresis)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Bell's Palsy"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,9/3/19,"```json
[
  {
    ""AE Term"": ""Bell's Palsy"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Facial stiffness (residual stiffness under left eye)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hemorrhoidal bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,9/17/19,"```json
[
  {
    ""AE Term"": ""Impaired concentration"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,10/1/19,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly mention any new or worsening adverse events. It states that ""all adverse events were reviewed with Dr. Floudas,"" but does not provide specific details about the adverse events themselves. Additionally, the note mentions that ""all her labs results today are within normal limits"" and that ""any abnormalities, unless addressed or treated, were not clinically significant."" Without explicit documentation of new or worsening adverse events, no data can be extracted for the requested format."
64f5309673cbf36a4298a56da2b87048,10/15/19,"```json
[
  {
    ""AE_Term"": ""Facial muscle twitching"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,10/29/19,"```json
[
  {
    ""AE_Term"": ""Facial muscle twitching"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,11/12/19,"```json
[
  {
    ""AE Term"": ""Facial nerve disorder"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Definite (related to recent Bell's Palsy diagnosis)""
    }
  },
  {
    ""AE Term"": ""Numbness of mouth and bottom lip"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Definite (related to recent Bell's Palsy diagnosis)""
    }
  },
  {
    ""AE Term"": ""Taste changes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Definite (related to recent Bell's Palsy diagnosis)""
    }
  },
  {
    ""AE Term"": ""Rectal hemorrhage"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,11/26/19,"```json
[
  {
    ""AE Term"": ""Rash maculo-papular"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Facial nerve disorder"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,12/10/19,"```json
[
  {
    ""AE Term"": ""Maculopapular rash"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Lichenoid Dermatitis"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,12/24/19,"```json
[
  {
    ""AE Term"": ""Rash to extremities"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,1/7/20,"```json
[
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Cough"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Rectal bleeding (secondary to hemorrhoids)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,1/21/20,"```json
[
  {
    ""AE Term"": ""Skin toxicities"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,1/27/20,"```json
[]
``` 

Explanation: The provided clinical note does not explicitly mention any new or worsening adverse events that emerged after the start of treatment. It only states that ""all adverse events reviewed and discussed with Dr. Strauss,"" without detailing specific adverse events, their grades, or attribution. Therefore, no extractable data is available based on the criteria provided."
64f5309673cbf36a4298a56da2b87048,2/4/20,"```json
[]
``` 

**Explanation:**
Based on the clinical note provided, there are no new or worsening adverse events (AEs) reported during this visit. The patient has recovered from prior adverse events, including lower left abdominal pain (resolved with tumor resection) and rash/lichenoid dermatitis (resolved with only scarring remaining). Bell's Palsy and skin toxicities were previously documented, and there is no indication in the note that these conditions have worsened or re-emerged. Therefore, no new or worsening AEs were identified for extraction."
64f5309673cbf36a4298a56da2b87048,3/17/20,"```json
[
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,5/12/20,"```json
[]
``` 

**Explanation:**
The clinical note explicitly states that ""all prior reported adverse events have resolved"" and the patient denies symptoms such as nausea, constipation, pruritus, and reports improved energy level and concentration. There are no mentions of new or worsening adverse events in the note. Therefore, no adverse events meet the criteria for extraction."
64f5309673cbf36a4298a56da2b87048,8/4/20,"```json
[
  {
    ""AE_Term"": ""Hypokalemia"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug/Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,10/28/20,"```json
[
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Neoplasm, Malignant - Brain lesion"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""No""
    }
  }
]
```"
64f5309673cbf36a4298a56da2b87048,12/17/20,"```json
[
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Neoplasm, Malignant - Brain lesion"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Eye Disorder - peripheral visual fields altered left eye, r/t brain lesion"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""No""
    }
  }
]
```"
b143468311134d27f4f8a7622a1d7235,12/24/18,"```json
[
  {
    ""AE Term"": ""Nausea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Flatulence"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
b143468311134d27f4f8a7622a1d7235,1/22/19,"```json
[
  {
    ""AE_term"": ""Small Bowel Obstruction (SBO)"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
b143468311134d27f4f8a7622a1d7235,2/5/19,"```json
[]
``` 

**Explanation:**  
The clinical note provided does not explicitly list any new or worsening adverse events (AEs) that emerged after the start of treatment. It mentions abnormal labs and clinical symptoms but states that none are considered clinically significant, serious adverse events (SAEs), or adverse events of special interest (AESIs) unless otherwise noted in physician and RN notes. Since no specific AEs are described in the text, there is no data to extract based on the criteria provided."
7d6b3003a0ab29e50e44cc5d6ffb2f39,11/23/18,"```json
[]
``` 

Explanation: The provided clinical note does not contain any information about new or worsening adverse events. It primarily includes administrative details, such as the reason for the visit, protocol documentation, and electronic signatures. No adverse events are described in the text."
7d6b3003a0ab29e50e44cc5d6ffb2f39,12/11/18,"```json
[]
``` 

**Explanation:**  
The provided clinical note does not mention any new or worsening adverse events after the start of treatment. It primarily describes protocol-related information, baseline symptoms, and administrative details. No adverse events are explicitly documented in the text."
7d6b3003a0ab29e50e44cc5d6ffb2f39,2/5/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no explicitly documented **new or worsening adverse events** that emerged or worsened after the start of treatment with M7824. The note mentions the patient's non-adherence to prescribed pain medication and subsequent rebound pain at night, but this appears to be related to her medication regimen rather than a new or worsening adverse event directly attributable to the treatment (M7824). Additionally, the adverse events summary is stated to follow in another progress note, which may contain relevant information not included in this text."
7d6b3003a0ab29e50e44cc5d6ffb2f39,2/7/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, all adverse events mentioned (fatigue, pain to sacral/anal area, chronic nausea) are described as baseline symptoms related to the patient's disease and past treatments. There is no mention of new or worsening adverse events after the start of treatment with m7824. Therefore, the output is an empty JSON list."
7d6b3003a0ab29e50e44cc5d6ffb2f39,2/19/19,"```json
[
  {
    ""AE Term"": ""Rash"",
    ""Grade"": ""Not specified (assumed worsening)"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
7d6b3003a0ab29e50e44cc5d6ffb2f39,3/5/19,"```json
[
  {
    ""AE Term"": ""Blood clot (Deep vein thrombosis or pulmonary embolism)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
7d6b3003a0ab29e50e44cc5d6ffb2f39,3/19/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events documented. The text explicitly states that abnormal labs and clinical symptoms were noted but none are considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted. Additionally, baseline intermittent nausea and anorexia are ongoing, but these are pre-existing conditions and not new or worsening adverse events. No other adverse events are described in the note."
7d6b3003a0ab29e50e44cc5d6ffb2f39,4/2/19,"```json
[
  {
    ""AE Term"": ""Pruritus (Itching)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
7d6b3003a0ab29e50e44cc5d6ffb2f39,4/16/19,"```json
[
  {
    ""AE Term"": ""Abdominal hernia pain"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
7d6b3003a0ab29e50e44cc5d6ffb2f39,4/29/19,"```json
[]
```

**Explanation**: The provided clinical note does not mention any new or worsening adverse events. It primarily documents the patient being taken off the study as a screen failure, with no specific adverse events described. Therefore, the output is an empty list."
7d6b3003a0ab29e50e44cc5d6ffb2f39,5/2/19,"```json
[
  {
    ""AE_Term"": ""Pruritus"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug/Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Skin lesions with skin breakage and bleeding"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug/Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""External ear discomfort (burning sensation)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug/Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""External ear peeling"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug/Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
7d6b3003a0ab29e50e44cc5d6ffb2f39,5/16/19,"```json
[
  {
    ""AE_Term"": ""Abdominal hernia pain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unrelated"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Keratoacanthoma (KA) lesions"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unrelated"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
7d6b3003a0ab29e50e44cc5d6ffb2f39,5/28/19,"```json
[]
```

**Explanation:**
The clinical note explicitly states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" There is no mention of any new or worsening adverse events in the provided text. Therefore, no adverse events are extracted."
7d6b3003a0ab29e50e44cc5d6ffb2f39,6/12/19,"```json
[
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
7d6b3003a0ab29e50e44cc5d6ffb2f39,6/25/19,"```json
[
  {
    ""AE Term"": ""Anxiety"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
7d6b3003a0ab29e50e44cc5d6ffb2f39,8/20/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that abnormal labs and clinical symptoms were reviewed but none were considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI). Additionally, the patient has no new complaints, and the study drug treatment remains on hold for previously noted rash and pruritis, which are not described as new or worsening. Therefore, no AEs meet the criteria for extraction."
ee21ede823037fd3671f67a68376422a,7/9/19,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) documented after the start of treatment with M7824. The symptoms mentioned (fatigue and dry mouth) are explicitly noted as baseline findings related to prior treatment and radiation, and there is no indication of any new or worsened symptoms since the initiation of the investigational drug."
ee21ede823037fd3671f67a68376422a,7/23/19,"```json
[
  {
    ""AE Term"": ""TSH Increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related"": ""Unlikely"",
      ""Drug/Device Intervention"": ""Probable"",
      ""Related to Other"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related"": ""Possible"",
      ""Drug/Device Intervention"": ""Probable"",
      ""Related to Other"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Platelet Count Decreased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related"": ""Possible"",
      ""Drug/Device Intervention"": ""Probable"",
      ""Related to Other"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Lymphocyte Count Decreased"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related"": ""Possible"",
      ""Drug/Device Intervention"": ""Probable"",
      ""Related to Other"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""White Blood Cells Decreased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related"": ""Possible"",
      ""Drug/Device Intervention"": ""Probable"",
      ""Related to Other"": ""Unrelated""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,7/23/19,"```json
[
  {
    ""AE Term"": ""Chest tightness"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Pruritus (Itching)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,8/6/19,"```json
[
  {
    ""AE_Term"": ""Skin lesions"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Possible (Prior history of HSV Zoster)""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,8/20/19,"```json
[
  {
    ""AE Term"": ""Cough (dry)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible (e.g., mucosal irritation or GI reflux)""
    }
  },
  {
    ""AE Term"": ""Postnasal drainage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible (e.g., mucosal irritation or GI reflux)""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,9/6/19,"```json
[
  {
    ""AE Term"": ""Increased serum creatinine"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Persistent cough"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Skin symptoms (potential worsening)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,9/11/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events explicitly described after the start of treatment. The note primarily discusses the patient's pre-existing conditions (Bronchiectasis and acute bronchitis) and the prescribed treatments (Levaquin, Mucinex, and incentive spirometer breather device). No new symptoms or worsening conditions are mentioned that could be attributed to the disease, drug/device intervention, or other causes."
ee21ede823037fd3671f67a68376422a,9/16/19,"```json
[
  {
    ""AE Term"": ""Worsening cough"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Intractable cough"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,9/23/19,"```json
[
  {
    ""AE Term"": ""Intractable cough"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related"": ""Probable"",
      ""Drug/Device Intervention"": ""Unrelated"",
      ""Related to Other"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related"": ""Probable"",
      ""Drug/Device Intervention"": ""Unrelated"",
      ""Related to Other"": ""Unrelated""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,10/1/19,"```json
[]
``` 

**Explanation:**
Based on the clinical note provided, there are no new or worsening adverse events (AEs) reported. The patient is described as stable with no new toxicities. Respiratory symptoms, including cough, have resolved, and the patient has completed treatment for bronchitis. While there is mention of mildly increased serum creatinine and BUN, this is attributed to hydration status and not explicitly identified as a new or worsening AE related to the treatment (M7824). Therefore, no AEs meet the criteria for extraction."
ee21ede823037fd3671f67a68376422a,10/16/19,"```json
[]
``` 

**Explanation:**
The clinical note explicitly states that the patient has ""no new complaints at this time"" and that ""all prior reported adverse events are stable."" Additionally, the note mentions that the right chest wall pain has resolved, prior dehydration has resolved, and the patient remains asymptomatic for anemia. There are no indications of new or worsening adverse events in this note."
ee21ede823037fd3671f67a68376422a,10/30/19,"```json
[
  {
    ""AE Term"": ""Bronchial infection"",
    ""Grade"": ""Not specified in the note (assume Grade 2 based on treatment with antibiotics and steroids)"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Acute kidney injury (AKI)"",
    ""Grade"": ""Not specified in the note (assume Grade 1 based on stable elevated creatinine)"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Notes:
1. **Bronchial infection**: The recurrence of symptoms related to the bronchial infection was reported after treatment started. While the patient had a prior diagnosis, the recurrence is considered a new event.
2. **Acute kidney injury (AKI)**: Elevated creatinine levels were attributed to prior Cisplatin treatment, but the AKI is noted as ongoing and stable. It is included as it may have worsened after treatment initiation."
ee21ede823037fd3671f67a68376422a,10/30/19,"```json
[]
``` 

**Explanation:** The provided clinical note does not mention any new or worsening adverse events. It primarily discusses a protocol adjustment related to skipping post-infusion vital signs due to the patient's travel plans. No adverse events are described in the text."
ee21ede823037fd3671f67a68376422a,11/13/19,"```json
[]
``` 

**Explanation:**
After reviewing the clinical note, there are no new or worsening adverse events (AEs) reported. The note mentions that the patient's prior bronchial/bronchiectasis symptoms have resolved, and there are no indications of emergent or worsening symptoms attributable to the treatment (M7824) or other factors. The anemia is stable and asymptomatic, and all other lab abnormalities are stable based on baseline. Therefore, no new or worsening AEs are identified for extraction."
ee21ede823037fd3671f67a68376422a,11/26/19,"```json
[
  {
    ""AE Term"": ""Right upper abdominal chest wall pain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Atrial flutter"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Atrial fibrillation"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Cough"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Elevated heart rate (tachycardia)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,12/10/19,"```json
[]
``` 

Explanation: The provided clinical note does not mention any new or worsening adverse events. It primarily discusses protocol consent and procedural details without reporting any symptoms or adverse events."
ee21ede823037fd3671f67a68376422a,12/10/19,"```json
[
  {
    ""AE Term"": ""Right upper quadrant abdominal pain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Increased keratoacanthoma (KA) lesions on torso"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Increased pain due to lesion"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,12/20/19,"```json
[
  {
    ""AE Term"": ""Tachycardia"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,12/24/19,"```json
[
  {
    ""AE_Term"": ""Infusion-related reaction"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Right hip pain radiating down the right leg"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
ee21ede823037fd3671f67a68376422a,1/21/20,"```json
[
  {
    ""AE Term"": ""Infusional reaction"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Probable (Radiation treatment)""
    }
  },
  {
    ""AE Term"": ""Skin toxicities"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Probable (Radiation treatment)""
    }
  },
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Probable (Radiation treatment)""
    }
  }
]
``` 

### Notes:
1. **Infusional reaction**: Clearly linked to the study drug (m7824) as it led to the drug being placed on hold.
2. **Fatigue**: Patient reported fatigue affecting ADLs, which improved recently. This was attributed to radiation treatment.
3. **Skin toxicities**: Resolving, likely related to radiation treatment.
4. **Pruritus**: Resolved, also likely related to radiation treatment.

No grades were explicitly mentioned in the note, so they are marked as ""Not specified."""
ee21ede823037fd3671f67a68376422a,3/3/20,"```json
[
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Keratoacanthoma (KA) lesion on left shoulder"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Renal insufficiency"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,1/23/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events documented after the start of treatment. All symptoms mentioned (e.g., gastrointestinal reflux, essential hypertension, hypercholesterolemia, seasonal allergies, and degenerative arthritis pain) are clearly noted as pre-existing conditions or baseline symptoms prior to the initiation of the protocol treatment. Therefore, no adverse events meet the criteria for extraction."
a24ee1ece206989032e3494ea3ee1061,2/4/19,"```json
[
  {
    ""AE Term"": ""Increased frequency of loose stools"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Very soft and loose stool consistency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Intermittent mild abdominal cramping"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,2/11/19,"```json
[
  {
    ""AE Term"": ""Hematuria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Worsening urinary frequency"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Worsening urinary urgency"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Worsening urinary incontinence"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,2/14/19,"```json
[
  {
    ""AE Term"": ""Hematuria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urinary incontinence"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Bladder spasms"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,2/19/19,"```json
[
  {
    ""AE_Term"": ""Hematuria"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Urinary urgency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Bladder spasm"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Leukopenia (ANC count low at 880)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,2/26/19,"Based on the provided clinical note, there is no specific mention of new or worsening adverse events (AEs) or their details such as AE terms, grades, or attribution. The note only states that adverse events were discussed and reviewed with Dr. Gatti-Mays, but it does not provide explicit information about the AEs themselves.

If you have additional clinical notes or details that explicitly describe new or worsening adverse events, please provide them, and I will assist in extracting the relevant information."
a24ee1ece206989032e3494ea3ee1061,3/5/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events explicitly mentioned. The note states that the patient's urinary symptoms have resolved, her ANC lab results have improved, and her lab abnormalities from baseline remain stable. Additionally, Dr. Strauss did not consider her ANC clinically significant based on her history of leukopenia at baseline. Therefore, no new or worsening adverse events were identified in this document."
a24ee1ece206989032e3494ea3ee1061,3/5/19,"```json
[]
```

**Explanation:**
The clinical note does not document any new or worsening adverse events (AEs) that emerged after the start of treatment. The note explicitly mentions that the patient's urinary symptoms have resolved, and her ANC (absolute neutrophil count) has improved since the last visit. Additionally, the leukopenia is noted as a baseline condition, and no other new or worsening symptoms are described. Therefore, there are no AEs to extract based on the provided criteria."
a24ee1ece206989032e3494ea3ee1061,3/19/19,"```json
[
  {
    ""AE Term"": ""Hematuria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Keratoacanthomas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,4/2/19,"```json
[
  {
    ""AE Term"": ""Leukopenia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hematuria (pink-tinged spotting)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Gingival bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,4/16/19,"Based on the provided clinical note, there are no explicitly documented new or worsening adverse events (AEs) that emerged after the start of treatment. The note explicitly states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific AEs are mentioned in the text, the output will reflect the absence of reportable AEs.

```json
[]
```"
a24ee1ece206989032e3494ea3ee1061,4/30/19,"```json
[
  {
    ""AE Term"": ""Skin lesion on nose"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Possible (e.g., glasses resting on nose)""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,5/6/19,"```json
[
  {
    ""AE_Term"": ""Skin lesion on nose"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,5/14/19,"```json
[
  {
    ""AE Term"": ""Forgetfulness"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Neulasta sensitivity reactions (chills/rigors, diarrhea with abdominal cramping)"",
    ""Grade"": ""Not specified in note (historical sensitivity reactions mentioned)"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Probable (Neulasta/Neupogen)""
    }
  }
]
```

### Notes:
1. **Forgetfulness**: The patient reported mild forgetfulness that started after returning from vacation, which is new since the treatment began. It is mapped to CTCAE as ""Forgetfulness"" and graded as 1 (mild). The attribution to m7824 is marked as ""Possible"" since it could be related to the treatment, but no definitive link is established.

2. **Neulasta sensitivity reactions**: The note mentions a history of sensitivity reactions (chills/rigors, diarrhea with abdominal cramping) to Neulasta and Neupogen. However, these are not new or worsening adverse events but rather historical reactions. They are included here for context but are not directly related to m7824.

3. **Other symptoms**: The slight elevation in serum calcium and stable anemia are not considered adverse events as they are not clinically significant or new/worsening.

4. **Grading and Attribution**: Where specific grades or attributions are not explicitly mentioned in the note, reasonable assumptions are made based on the provided information."
a24ee1ece206989032e3494ea3ee1061,5/28/19,"```json
[
  {
    ""AE Term"": ""Rash maculo-papular"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,6/11/19,"```json
[
  {
    ""AE_Term"": ""Rash"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Pruritus (Itching)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Neutropenia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Rigors (Post-Neulasta Injection)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Definite"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,6/25/19,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly mention any new or worsening adverse events. It states that all adverse events were reviewed and discussed, but does not provide specific details about new or worsening symptoms. Additionally, abnormal lab results are noted as stable based on baseline history or not clinically significant. Without explicit documentation of new or worsening adverse events, no data can be extracted."
a24ee1ece206989032e3494ea3ee1061,7/9/19,"```json
[
  {
    ""AE Term"": ""Muscle cramping (left calf)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible (e.g., increased physical activity in warm weather)""
    }
  },
  {
    ""AE Term"": ""Orthostatic lightheadedness"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible (e.g., positioning after sitting on gardening stool)""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,7/10/19,"```json
[]
```

**Explanation**: The provided clinical note does not mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily discusses scheduling issues related to a photography appointment and does not describe any symptoms or adverse events. Therefore, the output is an empty JSON list."
a24ee1ece206989032e3494ea3ee1061,7/23/19,"```json
[
  {
    ""AE_Term"": ""Chills"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": {
        ""Intervention"": ""Neulasta"",
        ""Attribution"": ""Probable""
      },
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Diarrhea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": {
        ""Intervention"": ""Neulasta"",
        ""Attribution"": ""Probable""
      },
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Abdominal cramping"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": {
        ""Intervention"": ""Neulasta"",
        ""Attribution"": ""Probable""
      },
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Nausea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": {
        ""Intervention"": ""Neulasta"",
        ""Attribution"": ""Probable""
      },
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Vomiting"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": {
        ""Intervention"": ""Neulasta"",
        ""Attribution"": ""Probable""
      },
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Pruritus"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": {
        ""Intervention"": ""M7824"",
        ""Attribution"": ""Probable""
      },
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Skin lesions"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": {
        ""Intervention"": ""M7824"",
        ""Attribution"": ""Probable""
      },
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,8/6/19,"```json
[
  {
    ""AE_Term"": ""Pruritus"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Skin lesions"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Neutropenia (ANC 750)"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Sensitivity reaction (rigors post Neulasta administration)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Gastrointestinal symptoms (requiring Bentyl and Imodium)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,8/20/19,"```json
[
  {
    ""AE_Term"": ""Pruritus"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Definite"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Skin lesions"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Definite"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,9/3/19,"```json
[
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,9/17/19,"```json
[
  {
    ""AE_Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Neutropenia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,10/1/19,"```json
[
  {
    ""AE Term"": ""Myelodysplastic Syndrome (MDS)"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible (Acitretin)""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,10/15/19,"```json
[
  {
    ""AE Term"": ""Myelodysplastic Syndrome (MDS)"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Possible (Acitretin)""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,10/29/19,"```json
[
  {
    ""AE_Term"": ""Myelodysplastic Syndrome (MDS)"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Anemia"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Neutropenia"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,11/12/19,"```json
[
  {
    ""AE Term"": ""Myelodysplastic Syndrome (MDS)"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Notes:
1. **Myelodysplastic Syndrome (MDS)** and **Anemia** are identified as new adverse events because they are explicitly mentioned as reasons for holding the study drug (M7824) and are not described as baseline symptoms.
2. The grade of these adverse events is not specified in the clinical note.
3. Attribution is inferred based on the context provided:
   - Both MDS and Anemia are likely related to the disease (possible) but are more strongly attributed to the study drug (probable) since the drug was held due to these events.
   - There is no indication of other contributing factors, so ""Related to Other?"" is marked as unlikely."
a24ee1ece206989032e3494ea3ee1061,11/26/19,"```json
[
  {
    ""AE Term"": ""Myelodysplastic Syndrome (MDS)"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,12/10/19,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) explicitly documented. The note mentions that all adverse events were reviewed and discussed, but it does not specify any new or worsening AEs that emerged after the start of treatment with M7824. Additionally, the patient is noted to have a complete response (CR) per irRECIST, and no specific new symptoms or worsening conditions are described."
a24ee1ece206989032e3494ea3ee1061,1/7/20,"```json
[]
``` 

**Explanation:**
Based on the clinical note provided, there are no explicitly documented new or worsening adverse events (AEs) that emerged after the start of treatment with M7824. The note mentions prior anemia likely related to Acitretin (discontinued), expected white blood cell abnormalities due to the patient's underlying MDS diagnosis, and stable hemoglobin levels. However, these are not new or worsening AEs attributable to the treatment with M7824. Therefore, the output is an empty JSON list."
a24ee1ece206989032e3494ea3ee1061,4/21/20,"```json
[
  {
    ""AE Term"": ""Keratoacanthoma"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Neutropenia (ANC 380)"",
    ""Grade"": ""3"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,7/14/20,"```json
[]
``` 

Explanation: Based on the provided clinical note, there is no explicit mention of new or worsening adverse events. The note states that all adverse events were reviewed and discussed, but it does not specify any new or worsening events that emerged after the start of treatment with M7824. Additionally, the abnormalities in white blood cells and low ANC are described as ""expected"" based on the patient's MDS diagnosis, which suggests these are baseline symptoms rather than new or worsening adverse events. Therefore, no adverse events meet the criteria for extraction."
a24ee1ece206989032e3494ea3ee1061,10/6/20,"```json
[
  {
    ""AE Term"": ""Rash - maculo-papular, pruritus, intermittent to lower back"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Neutrophil Count Decreased"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,1/5/21,"```json
[
  {
    ""AE Term"": ""Rash - maculo-papular, pruritus, intermittent to lower back"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Neutrophil Count Decreased"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""White Blood Cell Count Decreased"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,3/30/21,"```json
[
  {
    ""AE Term"": ""Neutrophil Count Decreased"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""White Blood Cell Count Decreased"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""Dysphagia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,6/22/21,"```json
[
  {
    ""AE Term"": ""Neutrophil Count Decreased"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""White Blood Cell Count Decreased"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""Dysphagia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,9/21/21,"```json
[
  {
    ""AE Term"": ""Neutrophil Count Decreased"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention? (Intervention: M7824)"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""White Blood Cell Count Decreased"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention? (Intervention: M7824)"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""Dysphagia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention? (Intervention: M7824)"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention? (Intervention: M7824)"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Urinary Tract Infection"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention? (Intervention: M7824)"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,12/14/21,"```json
[
  {
    ""AE Term"": ""Neutrophil Count Decreased"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""White Blood Cell Count Decreased"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Urinary Tract Infection"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  }
]
```"
a24ee1ece206989032e3494ea3ee1061,3/1/22,"```json
[]
``` 

### Explanation:
The clinical note explicitly states: ""No new adverse events to report for this visit."" Additionally, the listed adverse events (MDS, Neutrophil Count Decreased, White Blood Cell Count Decreased) are documented as pre-existing conditions or baseline symptoms that were present before treatment or unrelated to the drug/device intervention (M7824). Therefore, no new or worsening adverse events were identified for extraction."
a24ee1ece206989032e3494ea3ee1061,8/9/22,"```json
[]
``` 

Explanation: The clinical note provided does not mention any new or worsening adverse events. It primarily discusses the patient's completion of treatment and follow-up status, with no specific adverse events reported."
a24ee1ece206989032e3494ea3ee1061,8/9/22,"```json
[
  {
    ""AE Term"": ""Neutrophil count decreased"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  },
  {
    ""AE Term"": ""White blood cell count decreased"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Definite""
    }
  }
]
```"
d869dac0cc532b7676d237c1ac5a5f4e,12/18/18,"```json
[]
```

**Explanation**: The provided clinical note does not mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily discusses the patient's non-compliance, lack of response to follow-ups, and subsequent removal from the study. No specific symptoms or adverse events are described in the text."
0a6d8ed57bad6cc2158c1a3100d01de7,9/10/19,"```json
[]
``` 

**Explanation**: Based on the clinical note provided, there are no new or worsening adverse events (AEs) documented after the start of treatment with the investigational drug (M7824). The symptoms mentioned (rectal pain and hearing impairment) are explicitly noted as baseline symptoms, meaning they were present before treatment began. Therefore, no new AEs meet the criteria for extraction."
0a6d8ed57bad6cc2158c1a3100d01de7,9/24/19,"```json
[]
``` 

**Explanation:**
The clinical note explicitly states, ""No adverse events to report at this time."" Additionally, the intermittent pruritus and diagnosis of Notalgia Paresthetica were present for the past two years and are therefore considered baseline symptoms, not new or worsening adverse events. No other adverse events were documented as emerging or worsening after the start of treatment."
0a6d8ed57bad6cc2158c1a3100d01de7,10/8/19,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) reported. The patient explicitly states that she has ""no complaints at this time"" and that she ""tolerated her week #3 infusion well."" Additionally, the physician's assessment and lab results indicate no abnormalities or adverse findings. Therefore, no AEs meet the criteria for extraction."
0a6d8ed57bad6cc2158c1a3100d01de7,10/22/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, the patient reported no new complaints at this time and stated that she tolerated her Week #5 infusion well. There is no mention of new or worsening adverse events in the text. Therefore, the output is an empty JSON list, indicating no adverse events to report."
0a6d8ed57bad6cc2158c1a3100d01de7,11/5/19,"```json
[
  {
    ""AE Term"": ""Maculopapular rash"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Bleeding at intestinal stoma site"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
0a6d8ed57bad6cc2158c1a3100d01de7,11/5/19,"```json
[
  {
    ""AE Term"": ""Maculopapular rash"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Bleeding at intestinal stoma site"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Possible (e.g., mechanical irritation from appliance)""
    }
  }
]
```"
0a6d8ed57bad6cc2158c1a3100d01de7,11/19/19,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly mention any new or worsening adverse events. It states that ""all adverse events were reviewed with Dr. Abdul Sater,"" but does not specify the nature, severity, or attribution of any adverse events. Additionally, the patient is described as ""clinically stable,"" and no specific adverse events are documented as emerging or worsening after the start of treatment. Therefore, no adverse events can be extracted based on the information provided."
0a6d8ed57bad6cc2158c1a3100d01de7,12/3/19,"```json
[
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Probable (Pain regimen)""
    }
  }
]
```"
0a6d8ed57bad6cc2158c1a3100d01de7,12/17/19,"```json
[
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Pain regimen (narcotics, Gabapentin, Motrin)""
    }
  },
  {
    ""AE Term"": ""Radiographic disease progression"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Clinical symptoms of disease progression"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
0a6d8ed57bad6cc2158c1a3100d01de7,12/20/19,"```json
[]
``` 

**Explanation:**  
The clinical note provided does not mention any new or worsening adverse events. It primarily discusses the patient's screen failure and removal from the study due to not meeting the HLA A02 eligibility criteria. There is no mention of symptoms or adverse events that emerged or worsened after the start of treatment."
b162d352bbfe7f1ac571c079f3a91f96,1/21/20,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events documented after the start of treatment. All symptoms listed are baseline symptoms or conditions that were present before treatment, as explicitly noted in the text. Therefore, no adverse events meet the criteria for extraction."
b162d352bbfe7f1ac571c079f3a91f96,2/4/20,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) reported during this visit. The patient explicitly stated that she tolerated her week #1 infusion of M7824 without difficulty, and at the time of this visit, she had no complaints. Additionally, the note explicitly states, ""No adverse events to report at this visit."" Therefore, the output is an empty JSON list."
b162d352bbfe7f1ac571c079f3a91f96,2/18/20,"```json
[
  {
    ""AE Term"": ""Tenderness to palpation of lesion"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
b162d352bbfe7f1ac571c079f3a91f96,3/3/20,"```json
[
  {
    ""AE Term"": ""Myositis"",
    ""Grade"": ""Not specified in note (requires physician-reviewed AE sheet for exact grade)"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Myocarditis"",
    ""Grade"": ""Not specified in note (requires physician-reviewed AE sheet for exact grade)"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Notes:
- The clinical note indicates that the patient is being admitted for evaluation of myositis and myocarditis, which are considered new or worsening adverse events.
- The exact grades of the AEs are not provided in the note and would need to be confirmed from the physician-reviewed AE sheet.
- Attribution is inferred based on the context of the note, with the drug intervention (m7824) being the most likely cause. Disease-related attribution is also possible but less certain."
b162d352bbfe7f1ac571c079f3a91f96,3/5/20,"```json
[]
``` 

**Explanation**: The clinical note explicitly states that the patient ""underwent the MRI without complications or adverse events."" Therefore, there are no new or worsening adverse events to extract."
c6d12120838563dcd1a1241d48adab62,12/4/18,"```json
[
  {
    ""AE Term"": ""Rash on left chest"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Bump on right nare"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
c6d12120838563dcd1a1241d48adab62,12/18/18,"Based on the provided clinical note, there is no explicit mention of specific new or worsening adverse events (AEs) in the text. The note refers to ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet"" and directs the reader to the ""Free Text Progress Note for updated AEs."" Without access to the referenced AE sheet or progress note, no specific AEs can be extracted.

However, if we were to hypothetically extract AEs based on the structure provided, the JSON output would look like this:

```json
[]
```

This indicates that no new or worsening adverse events were explicitly documented in the provided text. If additional documentation (e.g., the AE sheet or progress note) becomes available, it would be necessary to review those for further details."
c3bb03af386a687b8eef3303f7886bda,10/1/19,"```json
[]
``` 

**Explanation:**  
The clinical note provided does not document any new or worsening adverse events after the start of treatment with m7824. All symptoms listed (e.g., dysphagia, cough, dry mouth, decreased lymphocyte count, and hyperglycemia) are explicitly noted as baseline conditions/symptoms and are not related to the disease or treatment. Therefore, no new or worsening adverse events were identified for extraction."
c3bb03af386a687b8eef3303f7886bda,10/15/19,"```json
[]
``` 

**Explanation:**  
The clinical note explicitly states:  
- ""Abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet dated today.""  
- ""No AEs noted for this visit.""  

This indicates that no new or worsening adverse events were identified during this visit. Therefore, the output is an empty JSON list."
c3bb03af386a687b8eef3303f7886bda,10/29/19,"```json
[
  {
    ""AE Term"": ""Inguinal hernia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
c3bb03af386a687b8eef3303f7886bda,11/12/19,"```json
[
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
c3bb03af386a687b8eef3303f7886bda,11/26/19,"```json
[
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
``` 

### Explanation:
- **Dyspnea** and **Constipation** are noted as ongoing issues in the clinical note. Since the note does not explicitly state that these symptoms were present at baseline, they are considered new or worsening adverse events.
- Both events are mild (Grade 1) based on the description.
- Attribution is assigned as ""Possible"" for disease-related causes and ""Unlikely"" for drug/device intervention (m7824), as there is no clear evidence linking these symptoms to the intervention. ""Unrelated"" is selected for ""Related to Other?"" since no other contributing factors are mentioned."
c3bb03af386a687b8eef3303f7886bda,12/10/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events explicitly mentioned. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet dated today."" Additionally, the patient reports improvements in breathing and resolution of constipation issues, which are positive changes rather than adverse events. No new or worsening symptoms attributable to the disease, drug/device intervention (m7824), or other causes are described in the text."
c3bb03af386a687b8eef3303f7886bda,12/24/19,"```json
[
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
c3bb03af386a687b8eef3303f7886bda,1/7/20,"```json
[]
```

### Explanation:
Based on the clinical note provided, there are no **new or worsening adverse events** explicitly mentioned. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet dated today."" Additionally, the patient's breathing has improved, constipation has resolved to baseline, and no other new or worsening symptoms are described. Therefore, no adverse events meet the criteria for extraction."
c3bb03af386a687b8eef3303f7886bda,1/21/20,"```json
[]
```

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet dated today."" Additionally, the patient reports improvements in breathing and constipation, which have resolved to baseline, and no new symptoms or worsening conditions are described. Therefore, no AEs meet the criteria for extraction."
c3bb03af386a687b8eef3303f7886bda,2/4/20,"```json
[
  {
    ""AE Term"": ""Pericardial effusion"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Upper Respiratory Infection (URI)"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible""
    }
  }
]
``` 

### Notes:
1. **Pericardial effusion**: The note indicates that the effusion was present at baseline but has increased, making it a worsening adverse event.
2. **Upper Respiratory Infection (URI)**: The patient reports cold symptoms, which are new and not mentioned as baseline symptoms.
3. **Grade**: The grade of the adverse events is not explicitly mentioned in the note, so it is marked as ""Not specified.""
4. **Attribution**: The attributions are inferred based on the context provided in the note."
c3bb03af386a687b8eef3303f7886bda,2/18/20,"```json
[
  {
    ""AE Term"": ""Pericardial effusion"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Notes:
1. The clinical note mentions ""continued monitoring and evaluation of pericardial effusion,"" which suggests this is an ongoing issue. However, since the treatment was held due to this condition, it is reasonable to infer that the pericardial effusion may have worsened or emerged after treatment initiation. The grade is not explicitly stated in the note.
2. No other new or worsening adverse events are explicitly mentioned in the provided text."
c3bb03af386a687b8eef3303f7886bda,3/3/20,"```json
[]
```

**Explanation:**
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet dated today."" However, no specific AEs are described in the text, and there is no indication of new or worsening symptoms directly attributable to the treatment or disease. Therefore, the output is an empty JSON list."
c3bb03af386a687b8eef3303f7886bda,3/11/20,"```json
[
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Possible (winter weather/mucosal drying)""
    }
  },
  {
    ""AE Term"": ""Lipase Increased"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Pericardial Effusion"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible (URI & baseline finding)""
    }
  }
]
```"
c3bb03af386a687b8eef3303f7886bda,5/11/20,"```json
[]
```

**Explanation:**  
The provided clinical note does not mention any new or worsening adverse events. It primarily discusses the deferral of a protocol visit due to COVID-19 concerns and the patient's awareness of the plan for the next scheduled visit. There is no mention of symptoms, adverse events, or changes in the patient's condition that emerged or worsened after the start of treatment."
c3bb03af386a687b8eef3303f7886bda,5/26/20,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events explicitly mentioned. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet dated today."" Additionally, the patient is described as continuing to feel well, and no specific adverse events are detailed in the text. Therefore, no adverse events meet the criteria for extraction."
c3bb03af386a687b8eef3303f7886bda,7/21/20,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events explicitly mentioned. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet dated today."" Additionally, the patient is described as continuing to feel well, with no indication of new or worsening symptoms or adverse events. Therefore, no adverse events are extracted."
c3bb03af386a687b8eef3303f7886bda,9/1/20,"```json
[
  {
    ""AE_Term"": ""Pericardial Effusion"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Possible""
    }
  }
]
```"
c3bb03af386a687b8eef3303f7886bda,10/20/20,"```json
[
  {
    ""AE Term"": ""Gastroesophageal Reflux Disease (GERD)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  }
]
```"
c3bb03af386a687b8eef3303f7886bda,12/1/20,"```json
[
  {
    ""AE Term"": ""Gastroesophageal Reflux"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Not Applicable""
    }
  },
  {
    ""AE Term"": ""Pericardial Effusion"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible (URI & baseline finding)""
    }
  }
]
```"
c3bb03af386a687b8eef3303f7886bda,1/12/21,"```json
[
  {
    ""AE Term"": ""Gastroesophageal Reflux"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": null
    }
  }
]
```"
c3bb03af386a687b8eef3303f7886bda,1/27/21,"```json
[]
``` 

**Explanation:** The clinical note provided does not mention any new or worsening adverse events. The patient decided not to participate in the trial and was not screened, meaning no treatment was initiated. Therefore, no adverse events related to treatment or disease progression can be extracted from this note."
7820df7c75ff9301d2adc15aa337db34,7/16/19,"```json
[]
``` 

**Explanation**:  
The clinical note provided does not document any new or worsening adverse events (AEs) that emerged after the start of treatment with M7824. All symptoms listed in the ""Baseline Symptoms/Findings"" section are explicitly noted as pre-existing conditions, either related to prior therapies, disease, or other causes. No new AEs or worsening of baseline symptoms are described in the note."
7820df7c75ff9301d2adc15aa337db34,7/29/19,"```json
[
  {
    ""AE Term"": ""Pain in right lower back"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Pain in right lower extremity"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
7820df7c75ff9301d2adc15aa337db34,7/31/19,"The provided clinical note does not explicitly list any new or worsening adverse events (AEs) or their details (e.g., AE term, grade, attribution). It only mentions that ""all adverse events [were] reviewed with Dr. Gatti-Mays."" Without specific AE information, it is not possible to extract or map AEs to CTCAE terminology or provide the requested details.

If you have additional clinical notes or documentation that explicitly describe new or worsening AEs, please provide them, and I will assist in extracting the relevant information."
7820df7c75ff9301d2adc15aa337db34,8/12/19,"```json
[
  {
    ""AE Term"": ""Dehydration"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related"": ""Probable"",
      ""Drug/Device Intervention"": ""Unrelated"",
      ""Related to Other"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related"": ""Probable"",
      ""Drug/Device Intervention"": ""Unrelated"",
      ""Related to Other"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Tachycardia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related"": ""Possible"",
      ""Drug/Device Intervention"": ""Unrelated"",
      ""Related to Other"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related"": ""Probable"",
      ""Drug/Device Intervention"": ""Unrelated"",
      ""Related to Other"": ""Unrelated""
    }
  }
]
```"
7820df7c75ff9301d2adc15aa337db34,8/23/19,"Based on the provided clinical note, there is no explicit mention of specific adverse events (AEs) or their details (e.g., AE term, grade, attribution). The note primarily references an ""Adverse Events Summary Update"" and mentions that all adverse events were reviewed with Dr. Strauss, but it does not provide the actual AE data.

If you have additional clinical notes or documentation that explicitly lists the adverse events, I can assist in extracting and formatting them. For now, the output would be an empty JSON list, as no new or worsening AEs are explicitly documented in the provided text.

```json
[]
```"
7820df7c75ff9301d2adc15aa337db34,8/28/19,"```json
[
  {
    ""AE Term"": ""Severe fatigue"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related"": ""Probable"",
      ""Drug/Device Intervention"": ""Unlikely"",
      ""Related to Other"": ""Possible (related to recent spinal surgery and radiation therapy)""
    }
  },
  {
    ""AE Term"": ""Decreased appetite"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related"": ""Probable"",
      ""Drug/Device Intervention"": ""Unlikely"",
      ""Related to Other"": ""Possible (related to recent spinal surgery and radiation therapy)""
    }
  },
  {
    ""AE Term"": ""Tachycardia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related"": ""Definite"",
      ""Drug/Device Intervention"": ""Unlikely"",
      ""Related to Other"": ""Possible (related to tumor affecting arteries near the heart)""
    }
  }
]
```"
df5d99e7acc6945774fa3fcc9ca6f4a2,12/17/19,"```json
[
  {
    ""AE Term"": ""Creatinine increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Hypercalcemia"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Lymphocyte count decreased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
df5d99e7acc6945774fa3fcc9ca6f4a2,12/31/19,"```json
[
  {
    ""AE Term"": ""Gingival bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Rectal bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
df5d99e7acc6945774fa3fcc9ca6f4a2,1/14/20,"```json
[
  {
    ""AE Term"": ""Allergic rhinitis (itchy ears and throat)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Cough (intermittent)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Chest tightness"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
df5d99e7acc6945774fa3fcc9ca6f4a2,1/28/20,"```json
[
  {
    ""AE Term"": ""Vaginal spotting"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
df5d99e7acc6945774fa3fcc9ca6f4a2,2/11/20,"```json
[
  {
    ""AE Term"": ""Pruritus (itching)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Rash (diffuse red bumps)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
df5d99e7acc6945774fa3fcc9ca6f4a2,2/25/20,"```json
[
  {
    ""AE Term"": ""Hematuria"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Increased bleeding"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
df5d99e7acc6945774fa3fcc9ca6f4a2,3/4/20,"```json
[
  {
    ""AE_term"": ""Hematuria"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease_Related"": ""Probable"",
      ""Drug_Device_Intervention"": ""Unrelated"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
df5d99e7acc6945774fa3fcc9ca6f4a2,3/10/20,"```json
[
  {
    ""AE Term"": ""Dysphagia"",
    ""Grade"": ""Not specified (assume Grade 2 based on clinical context of 'increasing dysphagia')"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Explanation:
- **Dysphagia**: The note explicitly mentions ""increasing dysphagia,"" indicating a worsening of this symptom. It is therefore considered a new or worsening adverse event.
- **Grade**: The grade is not explicitly mentioned in the note. Based on the clinical context (e.g., treatment being held and pending procedures), it is reasonable to assume at least Grade 2 severity.
- **Attribution**:
  - **Disease Related?**: Marked as ""Probable"" because the worsening dysphagia is likely due to disease progression, as explicitly mentioned in the note.
  - **Drug/Device Intervention?**: Marked as ""Unlikely"" because there is no indication in the note that the intervention (m7824) is contributing to this symptom.
  - **Related to Other?**: Marked as ""Unlikely"" because no other contributing factors are mentioned.

No other adverse events are explicitly described as new or worsening in the note."
df5d99e7acc6945774fa3fcc9ca6f4a2,3/25/20,"```json
[
  {
    ""AE Term"": ""Urinary tract infection symptoms"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Possible (e.g., unrelated factors such as travel or other medications)""
    }
  },
  {
    ""AE Term"": ""Hematuria (blood in urine)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Possible (e.g., related to UTI)""
    }
  }
]
``` 

### Explanation:
1. **Urinary tract infection symptoms** (bladder pressure, burning with urination) and **hematuria** (slight blood in urine) were reported on 3/21/20. These symptoms are considered new adverse events since they were not documented as baseline symptoms prior to treatment.
2. The symptoms improved after starting antibiotics (Macrobid), suggesting they were likely related to the UTI rather than the study drug (m7824) or the underlying disease.
3. No other new or worsening adverse events were reported in the note."
de5479020c2993d8b712e1f8595233c4,11/27/18,"```json
[]
``` 

Explanation: The provided clinical note does not explicitly list any new or worsening adverse events (AEs) that emerged after the start of treatment. It mentions abnormal labs and symptoms but states that none are clinically significant unless noted in the physician-reviewed AE sheet or Free Text Progress Note, which are not included in the provided text. Therefore, no AEs can be extracted based on the given information."
de5479020c2993d8b712e1f8595233c4,12/24/18,"Based on the provided clinical note, there is no explicit mention of specific adverse events (AEs) or their details (e.g., AE term, grade, attribution). The note refers to ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet"" and directs the reader to ""see Free Text Progress Note for updated AE's."" Without access to the Free Text Progress Note or the physician-reviewed AE sheet, it is not possible to extract specific new or worsening AEs from the provided text.

If additional documentation (e.g., the Free Text Progress Note or AE sheet) is available, it would be necessary to review that information to extract the required details.

For now, the output is as follows:

```json
[]
```

This indicates that no new or worsening adverse events could be extracted from the provided text. If more information becomes available, please provide it for further analysis."
de5479020c2993d8b712e1f8595233c4,1/22/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged or worsened after the start of treatment. The note states that ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in current physician note."" Since no specific AEs are described in this text, the output will reflect the absence of extractable AEs.

```json
[]
```"
de5479020c2993d8b712e1f8595233c4,2/19/19,"```json
[]
``` 

**Explanation:**  
The provided clinical note does not contain any information about new or worsening adverse events. It primarily includes general protocol information, documentation details, and electronic signatures. No adverse events are described in the text."
de5479020c2993d8b712e1f8595233c4,2/19/19,"```json
[]
``` 

**Explanation:**
The clinical note provided does not explicitly document any new or worsening adverse events (AEs) that emerged after the start of treatment. While the note mentions that adverse events were reviewed and discussed, it does not specify any new or worsening symptoms. Additionally, the rash and anemia mentioned in the note appear to be ongoing issues, with no indication that they are new or have worsened. Therefore, no AEs can be extracted based on the provided information."
de5479020c2993d8b712e1f8595233c4,2/26/19,"```json
[]
```

**Explanation:**  
The provided clinical note does not contain specific details about new or worsening adverse events. It only mentions that all adverse events and attributions were reviewed and approved by the attending physician but does not list any specific adverse events or their attributes. Therefore, no data can be extracted based on the criteria provided."
de5479020c2993d8b712e1f8595233c4,3/5/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that abnormal labs and clinical symptoms were observed but none were considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted in the physician and RN notes. Since no specific adverse events are described as new or worsening, the output is an empty JSON list."
de5479020c2993d8b712e1f8595233c4,3/19/19,"```json
[
  {
    ""AE Term"": ""Pruritus (itching)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Excoriations (skin abrasions from scratching)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
de5479020c2993d8b712e1f8595233c4,4/2/19,"```json
[
  {
    ""AE Term"": ""Pruritus (itching)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
de5479020c2993d8b712e1f8595233c4,4/16/19,"```json
[
  {
    ""AE Term"": ""Pruritus (Itching)"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
de5479020c2993d8b712e1f8595233c4,4/30/19,"```json
[
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Itching"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
de5479020c2993d8b712e1f8595233c4,5/14/19,"```json
[]
``` 

**Explanation:**
Based on the clinical note provided, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that ""itching and rash continue to improve, although not resolved,"" which indicates these symptoms were pre-existing and are improving rather than worsening. Additionally, the note specifies that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" No new or worsening AEs are explicitly documented in this text."
de5479020c2993d8b712e1f8595233c4,5/28/19,"```json
[
  {
    ""AE_Term"": ""Pruritus"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
de5479020c2993d8b712e1f8595233c4,6/11/19,"```json
[]
```

### Explanation:
The clinical note indicates that the patient has itching and rash (pruritus), but it is explicitly stated that these symptoms are improving and that the patient has stopped taking steroids. There is no mention of new or worsening adverse events in the note. Additionally, the note specifies that abnormal labs and clinical symptoms are not considered clinically significant, SAE, or AESI unless otherwise noted, and no such notes are present. Therefore, no new or worsening adverse events were identified."
de5479020c2993d8b712e1f8595233c4,6/25/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events (AEs) explicitly mentioned. The patient states they have ""no new complaints"" and have been ""feeling very well."" While the note mentions resolving rash and pruritis, these are not described as new or worsening symptoms but rather ongoing issues for which treatment is being held. Additionally, the note specifies that abnormal labs and clinical symptoms are not considered clinically significant, SAE, or AESI unless otherwise noted, and no such notes are present. Therefore, no AEs meet the criteria for extraction."
de5479020c2993d8b712e1f8595233c4,7/9/19,"```json
[
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
de5479020c2993d8b712e1f8595233c4,7/23/19,"```json
[
  {
    ""AE Term"": ""Diarrhea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Possible (likely related to food consumed at restaurant)""
    }
  },
  {
    ""AE Term"": ""Vomiting"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Possible (likely related to food consumed at restaurant)""
    }
  },
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Notes:
1. **Diarrhea and Vomiting**: These events were new and occurred after eating at a restaurant. They resolved without intervention and are likely unrelated to the treatment or disease but possibly related to food consumed.
2. **Pruritus**: This symptom is noted to be ongoing but improving. Since it is still present and treatment is being held due to rash and pruritus, it is attributed as ""Probable"" to the drug intervention (m7824). It is graded as 2 due to its impact on treatment continuation."
de5479020c2993d8b712e1f8595233c4,8/6/19,"```json
[
  {
    ""AE Term"": ""Imbalance"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Explanation:
- **AE Term**: ""Imbalance"" was identified as a worsening symptom since the patient reported that their imbalance issues have increased from baseline after their recent eye procedures.
- **Grade**: Assigned as Grade 1 because the patient stated it is not limiting their self-care ADLs (activities of daily living) any more than previously and no new falls were reported.
- **Attribution**:
  - **Disease Related?**: Marked as ""Possible"" because imbalance could be related to the underlying condition or disease progression.
  - **Drug/Device Intervention?**: Marked as ""Unlikely"" because the study drug treatment (m7824) is currently on hold, making it less likely to be the cause.
  - **Related to Other?**: Marked as ""Unlikely"" since no other clear contributing factors were mentioned in the note.

No other new or worsening adverse events were identified in the clinical note."
de5479020c2993d8b712e1f8595233c4,8/26/19,"```json
[
  {
    ""AE Term"": ""Imbalance"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Brain metastases"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Skin issues"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
de5479020c2993d8b712e1f8595233c4,9/3/19,"```json
[]
```

**Explanation**: The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The patient reports ""limited energy post surgery,"" but there is no indication that this is a new or worsening symptom attributable to the treatment (m7824) or the disease. Additionally, the note lacks sufficient detail to classify this as an AE under CTCAE terminology. Therefore, no AEs are extracted."
de5479020c2993d8b712e1f8595233c4,9/17/19,"```json
[]
``` 

**Explanation:**  
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) after the start of treatment. The patient reports ""limited energy post-surgery,"" but this appears to be related to recovery from surgery rather than a new or worsening AE attributable to the study drug (m7824), the disease, or other factors. Additionally, no specific CTCAE-terminology-mapped AE terms, grades, or attributions are provided in the text. Therefore, no AEs are extracted."
de5479020c2993d8b712e1f8595233c4,9/20/19,"Based on the provided clinical note, there is no mention of new or worsening adverse events (AEs) that emerged or worsened after the start of treatment. The note primarily discusses the treatment plan, logistics, and patient arrangements for admission and treatment. No symptoms or adverse events are described in the text.

As a result, the output is an empty JSON list:

```json
[]
```"
de5479020c2993d8b712e1f8595233c4,9/30/19,"```json
[]
``` 

Explanation: The provided clinical note does not contain specific details about new or worsening adverse events. It only mentions that all adverse events and attributions were reviewed and approved by the attending physician, without listing any specific AEs or their attributes. Therefore, no data can be extracted based on the criteria provided."
de5479020c2993d8b712e1f8595233c4,10/22/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged or worsened after the start of treatment. The note explicitly states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Additionally, there is no specific mention of new or worsening symptoms that meet the criteria for AEs.

As a result, the output JSON list will be empty:

```json
[]
``` 

If additional clinical notes or details are provided, I can reassess and extract relevant AEs accordingly."
de5479020c2993d8b712e1f8595233c4,10/31/19,"```json
[
  {
    ""AE Term"": ""Balance difficulties"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    },
    ""Start Date"": ""2019-08-19""
  }
]
```"
de5479020c2993d8b712e1f8595233c4,11/20/19,"```json
[]
```

**Explanation:**
The provided clinical note does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily discusses the patient's inability to travel due to weakness, but it does not provide sufficient detail to classify this as a new or worsening AE, nor does it attribute the weakness to the disease, drug/device intervention, or other causes. Therefore, no AEs are extracted."
c460e2e9af240ce9cf71067e48620eeb,10/22/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, all adverse events listed (e.g., decreased lymphocyte count, increased TSH, hyperglycemia, hematuria, cough, hoarseness) are explicitly marked as baseline conditions/symptoms and are not related to the disease or treatment. No new or worsening adverse events after the start of treatment are documented in the note. Therefore, the output is an empty JSON list."
c460e2e9af240ce9cf71067e48620eeb,11/5/19,"```json
[]
``` 

**Explanation**: Based on the clinical note provided, there are no new or worsening adverse events (AEs) documented. The patient reports right shoulder pain, but it is explicitly stated that this symptom has been present since before study enrollment and is possibly related to manual labor. Therefore, it does not qualify as a new or worsening AE. Additionally, the note mentions abnormal labs and/or symptoms but specifies that none are clinically significant unless otherwise noted in the physician-reviewed AE sheet, which is not provided in the text."
c460e2e9af240ce9cf71067e48620eeb,11/19/19,"```json
[
  {
    ""AE Term"": ""Dyspnea on exertion"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
c460e2e9af240ce9cf71067e48620eeb,12/3/19,"```json
[
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Increased TSH"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Elevated liver enzymes"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
c460e2e9af240ce9cf71067e48620eeb,12/23/19,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly list any new or worsening adverse events (AEs) that emerged or worsened after the start of treatment. It mentions that the patient expired on 12/18/19 and refers to a PI note dated 12/19/19 for details, but no specific AEs are described in the text. Additionally, all AEs are stated to have been reviewed and attributed by the PI, but the actual adverse events and their details are not included in the provided text. Therefore, no extractable AEs are present in this note."
76a31fecc63b4452993209c2b6e75de7,1/15/19,"```json
[]
``` 

**Explanation:**  
The clinical note provided does not explicitly list any new or worsening adverse events (AEs). It mentions abnormal labs and symptoms but states that none are clinically significant unless noted in the physician-reviewed AE sheet, which is not included in the provided text. Additionally, the note refers to updated AEs in the Free Text Progress Note, which is not part of the provided information. Therefore, no extractable AEs are present in the given text."
76a31fecc63b4452993209c2b6e75de7,1/29/19,"```json
[]
``` 

**Explanation:**  
The clinical note explicitly states that ""Abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" There is no mention of new or worsening adverse events in the provided text. Therefore, no adverse events meet the criteria for extraction."
76a31fecc63b4452993209c2b6e75de7,2/12/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events (AEs) identified that emerged or worsened after the start of treatment. The abnormal lab values from 12/11/19 were deemed to be a dilutional error and resolved upon repeat testing, and the patient's weight issues were noted as ongoing complaints without indication of worsening or emergence after treatment initiation. Therefore, no AEs meet the criteria for extraction."
76a31fecc63b4452993209c2b6e75de7,2/26/19,"```json
[]
```

### Explanation:
The clinical note provided does not explicitly describe any **new or worsening adverse events** that emerged after the start of treatment. The note mentions:

1. **Abnormal labs and clinical symptoms**: These are explicitly stated as ""not considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" No specific new or worsening AEs are detailed in this note.
2. **Skin lesions (KAs)**: The patient declined dermatology evaluation during this visit, and there is no indication that these lesions are new or worsening. They appear to be pre-existing.
3. **Weight issues**: The patient continues to complain about weight issues, but there is no indication that this is a new or worsening symptom since treatment began.

As no new or worsening adverse events are documented, the output is an empty JSON list."
76a31fecc63b4452993209c2b6e75de7,3/12/19,"```json
[
  {
    ""AE Term"": ""Epigastric chest discomfort"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
76a31fecc63b4452993209c2b6e75de7,3/26/19,"```json
[
  {
    ""AE_Term"": ""Keratoacanthoma"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug/Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
``` 

### Notes:
1. **Keratoacanthoma** is the only adverse event explicitly mentioned in the clinical note. It is described as the reason for the hold on the study medication (M7824), suggesting it emerged or worsened after treatment began.
2. The grade of the AE is not specified in the note, so it is left as ""Not specified.""
3. Attribution is inferred based on the context:
   - ""Unlikely"" for disease-related, as there is no indication it is due to the underlying condition.
   - ""Probable"" for drug/device intervention, as the medication (M7824) was held due to this AE.
   - ""Unlikely"" for other causes, as no other contributing factors are mentioned."
76a31fecc63b4452993209c2b6e75de7,4/9/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that abnormal labs and clinical symptoms were observed but none were considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted. Since no specific adverse events are described as new or worsening after the start of treatment, the output is an empty JSON list."
76a31fecc63b4452993209c2b6e75de7,4/23/19,"```json
[]
```

**Explanation:**
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. It states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific AEs are described in the text, there are no events to extract."
76a31fecc63b4452993209c2b6e75de7,5/7/19,"```json
[]
``` 

**Explanation:**
After reviewing the clinical note, there are no new or worsening adverse events (AEs) that emerged after the start of treatment. The symptoms mentioned (e.g., flu-like symptoms, wound dehiscence, leg edema, chronic gastritis, fecal incontinence, and anal hemorrhaging) are either resolved, improving, or baseline conditions that were present before treatment. Therefore, no new or worsening AEs were identified for extraction."
76a31fecc63b4452993209c2b6e75de7,5/22/19,"```json
[
  {
    ""AE_Term"": ""Keratoacanthomas"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
76a31fecc63b4452993209c2b6e75de7,6/4/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that abnormal labs and clinical symptoms were reviewed but none were considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted in the physician and RN notes. Since no specific new or worsening adverse events are documented, the output is an empty JSON list."
76a31fecc63b4452993209c2b6e75de7,6/18/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily describes a planned surgical procedure (Video-Assisted Thoracoscopy and Thoracotomy for Pulmonary Metastasectomy) and does not provide specific details about adverse events or their attribution.

If you have additional clinical notes or more detailed information about adverse events, please provide them for further analysis."
76a31fecc63b4452993209c2b6e75de7,6/19/19,"```json
[
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    },
    ""Start Date"": ""2018-08-14"",
    ""End Date"": ""2018-09-23""
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Probable (XRT and esophagitis)""
    },
    ""Start Date"": ""2018-09-23"",
    ""End Date"": ""2018-10-02""
  },
  {
    ""AE Term"": ""Keratoacanthomas"",
    ""Grade"": ""Not Specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Not Specified"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Not Specified"",
      ""Related to Other?"": ""Not Specified""
    },
    ""Start Date"": ""Ongoing""
  }
]
```"
55af5e66a032ff37979476659764d59a,9/3/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events documented after the start of treatment. The only symptom mentioned is ""Sinus Bradycardia, gr.1, unrelated to disease,"" which is explicitly noted as a baseline condition/symptom prior to treatment. Therefore, no new adverse events meet the criteria for extraction."
55af5e66a032ff37979476659764d59a,9/17/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events documented. The nasal congestion mentioned is explicitly stated as a baseline condition that began prior to enrollment in the study (~8/21/19) and is unrelated to the disease or the drug/device intervention (m7824). No other adverse events are described in the note."
55af5e66a032ff37979476659764d59a,10/1/19,"```json
[
  {
    ""AE Term"": ""Infusion related reaction"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
55af5e66a032ff37979476659764d59a,10/15/19,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly mention any new or worsening adverse events. It states that abnormal labs and symptoms were noted but none were clinically significant unless otherwise documented in the physician-reviewed AE sheet. Since no specific adverse events are described in the text, there is no data to extract based on the criteria provided."
55af5e66a032ff37979476659764d59a,10/29/19,"```json
[
  {
    ""AE Term"": ""Rectal symptoms"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Hemorrhoid"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
55af5e66a032ff37979476659764d59a,11/12/19,"```json
[
  {
    ""AE Term"": ""Blurred vision"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
55af5e66a032ff37979476659764d59a,11/26/19,"```json
[
  {
    ""AE Term"": ""Nasal congestion"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
55af5e66a032ff37979476659764d59a,12/10/19,"```json
[
  {
    ""AE Term"": ""Sinusitis"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable (steroids and antibiotics)""
    }
  },
  {
    ""AE Term"": ""Inflammation"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable (steroids and antibiotics)""
    }
  }
]
```"
55af5e66a032ff37979476659764d59a,12/24/19,"```json
[]
``` 

Explanation: The provided clinical note does not mention any new or worsening adverse events. It only describes the patient's decision to miss a scheduled protocol visit due to holiday plans with family. No symptoms, adverse events, or changes in health status are documented in the text."
55af5e66a032ff37979476659764d59a,1/7/20,"```json
[]
```

### Explanation:
The clinical note indicates that the patient experienced headaches, rash, and pruritus, but these symptoms have resolved with steroid use. There is no mention of new or worsening adverse events in the note. Additionally, the note specifies that abnormal labs and symptoms were noted but none were clinically significant unless otherwise documented in the physician-reviewed AE sheet, which is not provided here. Therefore, no new or worsening adverse events can be extracted from this note."
55af5e66a032ff37979476659764d59a,1/21/20,"```json
[
  {
    ""AE Term"": ""Sinusitis"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Definite (Antibiotic allergy)""
    }
  }
]
```"
55af5e66a032ff37979476659764d59a,2/18/20,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events explicitly mentioned that emerged or worsened after the start of treatment. The note primarily discusses ongoing sinus and allergy issues, which appear to be baseline symptoms, and no clinically significant adverse events are noted unless otherwise documented in the physician-reviewed AE sheet. Therefore, no adverse events meet the criteria for extraction."
55af5e66a032ff37979476659764d59a,4/16/20,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly described that emerged or worsened after the start of treatment with m7824. The note primarily discusses deferred visits, ongoing sinus and allergy issues (which appear to be baseline symptoms), and logistical updates related to COVID-19 precautions. No new adverse events are reported."
55af5e66a032ff37979476659764d59a,4/28/20,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) reported. The patient mentions improving sinus and allergy issues, which suggests these symptoms are resolving rather than worsening. Additionally, there are no indications of new symptoms or adverse events that have emerged after the start of treatment. Therefore, the output is an empty JSON list."
55af5e66a032ff37979476659764d59a,5/11/20,"```json
[]
``` 

**Explanation:**  
The provided clinical note does not mention any new or worsening adverse events. It primarily discusses scheduling changes due to COVID-19 concerns and the patient's plan for imaging and follow-up. There is no documentation of symptoms, adverse events, or changes in the patient's condition that emerged or worsened after the start of treatment."
55af5e66a032ff37979476659764d59a,11/17/20,"```json
[]
``` 

**Explanation**: The provided clinical note does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily discusses the patient's follow-up visit, protocol status, and a correction regarding the treatment status. No specific symptoms or adverse events are described in the text."
55af5e66a032ff37979476659764d59a,12/10/21,"```json
[]
``` 

**Explanation**: The clinical note provided does not mention any new or worsening adverse events. The patient states they are feeling well and are not undergoing any anti-cancer therapies. There is no indication of symptoms or adverse events that emerged or worsened after the start of treatment."
91f21fa70ee3bc8bbea83a1282f266cf,12/26/18,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no specific new or worsening adverse events explicitly mentioned. The note states that abnormal labs and/or symptoms were noted but none were clinically significant unless otherwise documented in the physician-reviewed AE sheet. Additionally, the note refers to updated AEs in the Free Text Progress Note, which is not included in the provided text. Therefore, no adverse events can be extracted from the given information."
91f21fa70ee3bc8bbea83a1282f266cf,2/19/19,"```json
[]
``` 

**Explanation:**  
The provided clinical note does not explicitly mention any new or worsening adverse events. It states that Dr. Sheth reviewed prior and new adverse event complaints, but the actual adverse events summary is not included in the text. Without specific details about new or worsening adverse events, no data can be extracted."
91f21fa70ee3bc8bbea83a1282f266cf,2/26/19,"```json
[]
``` 

Explanation: The provided clinical note does not contain specific information about new or worsening adverse events. It only mentions that all adverse events and attributions were reviewed and approved by the attending physician, without listing any specific AEs or their details. Therefore, no adverse events can be extracted based on the given text."
91f21fa70ee3bc8bbea83a1282f266cf,3/5/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged or worsened after the start of treatment. The note states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Additionally, there is no specific mention of new AEs or their details (e.g., AE term, grade, attribution) in the text.

As a result, the output JSON list will be empty:

```json
[]
```

If additional clinical notes or details are provided, I can reassess and extract relevant AEs accordingly."
91f21fa70ee3bc8bbea83a1282f266cf,3/18/19,"```json
[
  {
    ""AE Term"": ""Soft stools"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
91f21fa70ee3bc8bbea83a1282f266cf,4/2/19,"```json
[
  {
    ""AE Term"": ""Soft stools"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible (Probiotic yogurt consumption)""
    }
  }
]
```"
91f21fa70ee3bc8bbea83a1282f266cf,4/16/19,"```json
[]
```

### Explanation:
Based on the clinical note provided, there are no **new or worsening adverse events (AEs)** identified that emerged or worsened after the start of treatment. The symptoms mentioned in the note, such as ""soft stools"" and ""leg muscle weakness,"" appear to be ongoing and not newly reported or worsening. Additionally, the note explicitly states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Therefore, no new AEs meet the criteria for extraction."
91f21fa70ee3bc8bbea83a1282f266cf,4/30/19,"Based on the provided clinical note, there are no explicit mentions of new or worsening adverse events (AEs) that emerged or worsened after the start of treatment. The note explicitly states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific AEs are described in the text, the output will reflect the absence of reportable AEs.

```json
[]
```"
91f21fa70ee3bc8bbea83a1282f266cf,5/14/19,"```json
[]
```

**Explanation:**
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific new or worsening AEs are described in the text, there are no events to extract."
91f21fa70ee3bc8bbea83a1282f266cf,5/23/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events documented. The note explicitly states that the pain and discomfort in the left lower extremity (LLE) are baseline symptoms related to prior radiation therapy and not related to the disease or treatment. Therefore, no adverse events meet the criteria for extraction."
91f21fa70ee3bc8bbea83a1282f266cf,5/31/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Additionally, no specific new or worsening symptoms are described in the text. Therefore, the output is an empty JSON list."
91f21fa70ee3bc8bbea83a1282f266cf,6/11/19,"```json
[
  {
    ""AE Term"": ""Dizziness"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Potential GI bleeding"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
91f21fa70ee3bc8bbea83a1282f266cf,6/25/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that abnormal labs and clinical symptoms were reviewed but none were considered clinically significant, serious adverse events (SAEs), or adverse events of special interest (AESIs). Additionally, the patient reported no new complaints, and the leg neuropathy was described as a baseline symptom with slow signs of improvement. Therefore, no new or worsening AEs were identified for extraction."
91f21fa70ee3bc8bbea83a1282f266cf,7/9/19,"```json
[
  {
    ""AE Term"": ""Dizziness"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Potential GI bleeding"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Neuropathy"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
91f21fa70ee3bc8bbea83a1282f266cf,7/23/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events explicitly mentioned. The note states that abnormal labs and clinical symptoms were observed but none were considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted in the physician and RN notes. Since no specific adverse events are detailed in the text, there is no data to extract."
91f21fa70ee3bc8bbea83a1282f266cf,8/6/19,"```json
[]
``` 

**Explanation:**
Based on the clinical note provided, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Additionally, the left leg lymphedema is described as remaining ""as before,"" indicating it is not a new or worsening condition. No other adverse events are explicitly described as new or worsening after the start of treatment."
91f21fa70ee3bc8bbea83a1282f266cf,8/20/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that abnormal labs and clinical symptoms were observed but none were considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI). Additionally, the attending physician reviewed and approved all adverse events, and no new or worsening AEs were documented in this specific note."
91f21fa70ee3bc8bbea83a1282f266cf,9/3/19,"```json
[]
``` 

### Explanation:
Based on the clinical note provided, there are no **new or worsening adverse events** explicitly mentioned. The note states that the patients edema in bilateral legs has resolved and returned to baseline lymphedema in the left leg only. Weakness, pain, and paresthesia are noted to ""continue as before,"" indicating these symptoms were pre-existing and not new or worsening. Additionally, while treatment is being held due to potential GI bleeding and ongoing AEs, no specific new or worsening adverse events are described in the text. Therefore, the output is an empty JSON list."
91f21fa70ee3bc8bbea83a1282f266cf,9/18/19,"```json
[]
```

### Explanation:
The clinical note does not explicitly mention any **new or worsening adverse events** that emerged after the start of treatment. The note states that ""other adverse events remain the same,"" indicating no worsening of previously reported AEs. Additionally, the patient reports improvement in diarrhea, which does not qualify as a new or worsening AE. Therefore, no adverse events meet the criteria for extraction."
91f21fa70ee3bc8bbea83a1282f266cf,11/12/19,"```json
[
  {
    ""AE Term"": ""Diarrhea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Tinnitus"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Hot flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
91f21fa70ee3bc8bbea83a1282f266cf,12/17/19,"```json
[]
``` 

### Explanation:
Based on the clinical note provided, there are no **new or worsening adverse events** explicitly mentioned. The note states that the patient reported resolution of tinnitus and dizziness after a neurology consult, and while there are ongoing adverse events (e.g., paresthesia, muscle weakness, lymphedema, and potential GI bleeding), these are not explicitly described as new or worsening since the start of treatment. Additionally, the note specifies that abnormal labs and clinical symptoms are not considered clinically significant unless otherwise noted, and no new AEs are highlighted in the physician or RN notes."
91f21fa70ee3bc8bbea83a1282f266cf,1/21/20,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no **new or worsening adverse events** documented. The patient reports ongoing symptoms of leg muscle weakness, lymphedema, and paresthesia, which appear to be baseline symptoms as they are not described as new or worsening. Additionally, the resolution of eye cloudiness is noted, but this is an improvement rather than an adverse event. The note explicitly states that abnormal labs and clinical symptoms are not considered clinically significant unless otherwise noted, and no new AEs are identified in the physician or RN notes."
91f21fa70ee3bc8bbea83a1282f266cf,4/20/20,"```json
[]
```

**Explanation**: The provided clinical note does not mention any new or worsening adverse events. It primarily contains administrative and scheduling information related to the patient's follow-up visit, which was deferred due to COVID-19 precautions. No clinical symptoms or adverse events are described in the text."
91f21fa70ee3bc8bbea83a1282f266cf,6/9/20,"```json
[]
```

**Explanation:**
Based on the clinical note provided, there are no new or worsening adverse events (AEs) explicitly mentioned. The patient reports ongoing symptoms such as leg muscle weakness, lymphedema, intermittent diarrhea, and pain, but these are described as pre-existing conditions and not new or worsening since the start of treatment. Additionally, the note explicitly states that ""none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes,"" and no new AEs are highlighted in the text."
91f21fa70ee3bc8bbea83a1282f266cf,10/20/20,"```json
[
  {
    ""AE Term"": ""Diarrhea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Headache"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
5afd3991622b7c89cbca6bb4fd725221,11/27/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, all adverse events listed (fatigue, anorexia, pain, constipation) are baseline symptoms that were present before the start of treatment with M7824. No new or worsening adverse events after the initiation of treatment are documented in this note. Therefore, the output is an empty JSON list."
5afd3991622b7c89cbca6bb4fd725221,12/10/19,"```json
[
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Probable (Narcotic pain medications)""
    }
  }
]
```"
5afd3991622b7c89cbca6bb4fd725221,12/13/19,"```json
[]
```

### Explanation:
The clinical note does not describe any **new or worsening adverse events** that emerged after the start of treatment. The report mentions constipation, but it appears to have been a pre-existing condition (""prior report of constipation from clinic visit""). The note also indicates that the patient is managing the condition with prescribed medications (Lactulose, Senekot, Miralax) and has had bowel movements without complications (e.g., no blood in stool). Therefore, no new or worsening AEs are identified in this note."
5afd3991622b7c89cbca6bb4fd725221,12/24/19,"```json
[
  {
    ""AE Term"": ""Rectal Hemorrhage"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Increased Bilirubin"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
5afd3991622b7c89cbca6bb4fd725221,12/26/19,"Based on the provided clinical note, there is no explicit mention of specific new or worsening adverse events (AEs) that emerged after the start of treatment. The note only states that ""all adverse events were discussed and reviewed with Dr. Julius Strauss,"" but it does not provide detailed information about the AEs themselves, their grades, or their attributions.

If you have additional clinical notes or documentation that explicitly describe the adverse events, please provide them, and I can assist further."
5afd3991622b7c89cbca6bb4fd725221,12/31/19,"```json
[
  {
    ""AE Term"": ""Fatigue (falling asleep at the wheel)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Transportation difficulty due to fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Elevated bilirubin"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
5afd3991622b7c89cbca6bb4fd725221,1/7/20,"```json
[
  {
    ""AE Term"": ""Serum amylase increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hyponatremia"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
5afd3991622b7c89cbca6bb4fd725221,1/13/20,"```json
[]
```

**Explanation**: The provided clinical note does not explicitly describe any new or worsening adverse events (AEs) that emerged after the start of treatment. While it mentions that adverse events were reviewed and discussed with Dr. Floudas, no specific AEs, their grades, or attributions are detailed in the text. Therefore, no extractable data is available for this request."
5afd3991622b7c89cbca6bb4fd725221,1/20/20,"```json
[
  {
    ""AE Term"": ""Abdominal pain"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Abdominal distension"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Fever"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Notes:
- The clinical note does not specify the grades of the adverse events, so ""Grade"" is marked as ""Not specified.""
- The attribution is inferred based on the context provided, assuming the events occurred after the start of treatment and could be related to the disease or the intervention (m7824).
- Baseline symptoms are excluded, as per the instructions."
5afd3991622b7c89cbca6bb4fd725221,1/28/20,"```json
[
  {
    ""AE Term"": ""Hypokalemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
5afd3991622b7c89cbca6bb4fd725221,2/4/20,"```json
[]
``` 

Explanation: The provided clinical note does not explicitly mention any new or worsening adverse events. It only states that all adverse events were reviewed and discussed with Dr. Strauss, but no specific adverse events are detailed in the text. Additionally, there is no information indicating the emergence or worsening of symptoms after the start of treatment. Therefore, the output is an empty JSON list."
0a1b939444c4adcb1393c65274a17355,11/20/18,"Based on the provided clinical note, there is no explicit mention of specific adverse events (AEs) or their details (e.g., AE term, grade, attribution). The note refers to abnormal labs and symptoms but states that none are clinically significant unless otherwise noted in the physician-reviewed AE sheet or Free Text Progress Note. Without access to the Free Text Progress Note or AE sheet, no new or worsening adverse events can be extracted from the provided text.

If you have additional information or access to the Free Text Progress Note or AE sheet, please provide it so I can assist further."
0a1b939444c4adcb1393c65274a17355,12/4/18,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) in the text. The note refers to ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet"" and directs the reader to ""See Free Text Progress Note for updated AEs."" However, no specific AEs are described in the provided text.

If you have access to the referenced ""Free Text Progress Note"" or the ""physician-reviewed AE sheet,"" those documents may contain the necessary details to extract AEs. For now, based on the provided information, the output is as follows:

```json
[]
``` 

If additional information becomes available, please provide it for further analysis."
0a1b939444c4adcb1393c65274a17355,12/31/18,"```json
[]
``` 

Explanation: The clinical note does not explicitly mention any new or worsening adverse events. It states that abnormal labs and symptoms were noted but none were clinically significant unless otherwise documented in the physician-reviewed AE sheet. Additionally, no specific adverse events are described in the text provided. Therefore, no new or worsening adverse events can be extracted based on the information given."
6cc9a1944d2e3ac159dc4a4dd2277176,2/12/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, all adverse events listed are baseline symptoms that were present before the start of treatment. No new or worsening adverse events after the initiation of treatment are documented in the note. Therefore, the output is an empty JSON list."
6cc9a1944d2e3ac159dc4a4dd2277176,2/26/19,"```json
[
  {
    ""AE Term"": ""Leg pain"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
6cc9a1944d2e3ac159dc4a4dd2277176,3/12/19,"```json
[
  {
    ""AE Term"": ""Dyspnea on exertion"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anemia (increasing severity)"",
    ""Grade"": ""3"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
6cc9a1944d2e3ac159dc4a4dd2277176,3/26/19,"```json
[
  {
    ""AE Term"": ""Hydronephrosis"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Nausea"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Increased adenopathy"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
6cc9a1944d2e3ac159dc4a4dd2277176,3/28/19,"```json
[]
```

**Explanation:**
The clinical note provided does not explicitly document any new or worsening adverse events (AEs) that emerged after the start of treatment. While it mentions a ""pain crisis"" that occurred overnight, there is no clear indication that this is a new or worsening symptom attributable to the treatment (m7824) or other factors. Additionally, the note does not provide sufficient details to assign a CTCAE term, grade, or attribution. Therefore, no AEs can be extracted based on the provided information."
6cc9a1944d2e3ac159dc4a4dd2277176,4/10/19,"```json
[
  {
    ""AE Term"": ""Oral mucositis"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Deep vein thrombosis (DVT)"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Leg swelling"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
6cc9a1944d2e3ac159dc4a4dd2277176,4/18/19,"```json
[
  {
    ""AE Term"": ""Pneumonia"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
6cc9a1944d2e3ac159dc4a4dd2277176,4/19/19,"```json
[]
```

### Explanation:
The clinical note specifies that the patient's anemia was ongoing as of 2/26/19 and was retrospectively determined to be **unlikely related to the study drug (M7824)**, **probably related to the disease**, and **probably related to prior radiation, chemotherapies, and Lovenox**. However, there is no indication in the note that the anemia is a **new or worsening adverse event** after the start of treatment with M7824. Therefore, no new or worsening adverse events are extracted from this note."
03b2e85588ad5649532819daf87797a7,2/19/19,"```json
[
  {
    ""AE Term"": ""Rectal bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
03b2e85588ad5649532819daf87797a7,2/24/19,"```json
[
  {
    ""AE Term"": ""Rectal bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
03b2e85588ad5649532819daf87797a7,4/3/19,"```json
[]
```

**Explanation:**
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note only states that the patient missed the week 9 visit due to undergoing further back surgery, but it does not provide any details about new or worsening symptoms or adverse events. Therefore, no AEs can be extracted based on the provided information."
08b7f8ae708607415cb6d91315044748,8/6/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events documented after the start of treatment with M7824. The baseline symptoms (anorexia, decreased appetite, and mild fatigue) were explicitly noted to have been present since July 2018, prior to the initiation of the investigational drug. No additional adverse events or worsening of baseline symptoms were reported in this note."
08b7f8ae708607415cb6d91315044748,8/20/19,"```json
[
  {
    ""AE_Term"": ""Alanine aminotransferase increased"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,8/26/19,"```json
[
  {
    ""AE Term"": ""Fever"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Probable (related to drain capping)""
    }
  },
  {
    ""AE Term"": ""Chills"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Probable (related to drain capping)""
    }
  },
  {
    ""AE Term"": ""Leakage at insertion site of left drain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Probable (related to drain capping)""
    }
  },
  {
    ""AE Term"": ""Elevated liver panel results"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Probable (related to drain capping)""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,9/3/19,"```json
[
  {
    ""AE Term"": ""Fever"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Definite (Biliary drains)""
    }
  },
  {
    ""AE Term"": ""Elevated liver enzymes"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,9/18/19,"```json
[
  {
    ""AE Term"": ""Elevated liver enzymes"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dehydration"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Weight loss"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Reflux of oral fluids and food particles into biliary drain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,10/1/19,"```json
[
  {
    ""AE Term"": ""Increased liver enzymes"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Increased pancreatic enzymes (amylase and lipase)"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Biliary drain reflux"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Possible (drain malfunction)""
    }
  },
  {
    ""AE Term"": ""Dehydration"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Probable (biliary drain reflux)""
    }
  },
  {
    ""AE Term"": ""Altered nutrition"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Probable (biliary drain reflux)""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,10/15/19,"```json
[]
```

### Explanation:
Based on the clinical note provided, there are no **new or worsening adverse events** reported during this visit. The patient mentioned that the presence of blood while wiping after bowel movements and discomfort at biliary drain sites had resolved, indicating these were prior adverse events that have improved. No other new or worsening symptoms were documented."
08b7f8ae708607415cb6d91315044748,10/29/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged after the start of treatment with m7824. The note states that ""all adverse events were reviewed with Dr. Strauss,"" but it does not specify any new or worsening symptoms. Additionally, the patient is described as ""doing well,"" with stable restaging scans, no issues with biliary drains, regained weight, and labs within normal limits.

Since no specific new or worsening AEs are documented in the note, the output will be an empty JSON list:

```json
[]
``` 

If there are additional notes or details in other sections of the patient's records, those would need to be reviewed to identify any relevant AEs."
08b7f8ae708607415cb6d91315044748,11/12/19,"```json
[
  {
    ""AE Term"": ""Hematuria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Gingival bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,11/26/19,"```json
[
  {
    ""AE_Term"": ""Fever"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Probable""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,12/10/19,"```json
[
  {
    ""AE_Term"": ""Hemorrhoidal bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,12/24/19,"```json
[
  {
    ""AE_Term"": ""Biliary drain leakage"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Probable"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Fever"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Probable"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Lesion to right upper lip"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,1/7/20,"```json
[
  {
    ""AE_Term"": ""Biliary drain site leakage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Lip lesion enlargement"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Probable"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Papules on left and right shoulder"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,1/21/20,"```json
[
  {
    ""AE Term"": ""Abdominal pain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Fever"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Nausea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Cholecystitis"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Spontaneous pneumothorax"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Left middle finger bump"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  }
]
```"
08b7f8ae708607415cb6d91315044748,1/30/20,"```json
[]
``` 

**Explanation**: The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily describes the patient's discharge status, which indicates stability (e.g., ""incision site asymptomatic,"" ""pneumothorax resolved,"" ""drainage bags capped with no leaks observed""). There is no mention of new or worsening symptoms or adverse events. Therefore, the output is an empty JSON list."
08b7f8ae708607415cb6d91315044748,2/20/20,"```json
[
  {
    ""AE_Term"": ""Fever"",
    ""Grade"": ""Not specified in the note"",
    ""Attribution"": {
      ""Disease_Related"": ""Not specified in the note"",
      ""Drug_Device_Intervention"": ""Not specified in the note"",
      ""Related_to_Other"": ""Not specified in the note""
    }
  }
]
``` 

**Note**: The clinical note does not provide specific details about the grade or attribution of the adverse event (fever). If additional context or documentation is available, these details should be clarified and updated accordingly."
08b7f8ae708607415cb6d91315044748,2/28/20,"```json
[]
```

**Explanation**: The provided clinical note does not explicitly list any new or worsening adverse events (AEs) that emerged after the start of treatment. The note mentions that adverse events were updated and reviewed, but it does not provide specific details about the AEs, their grades, or their attributions. Without explicit information, no AEs can be extracted."
08b7f8ae708607415cb6d91315044748,3/17/20,"```json
[]
``` 

Explanation: Based on the clinical note provided, all adverse events mentioned (rashes, keratoacanthomas, oral bleeding, hemorrhoidal bleeding, and hematuria) are noted to have resolved. Additionally, there is no mention of new or worsening adverse events that emerged after the start of treatment with M7824. Therefore, the output is an empty JSON list."
fc68f402183b853a44935936ce8a3be4,12/11/18,"```json
[]
```

**Explanation**: The provided clinical note does not document any new or worsening adverse events (AEs) after the start of treatment. It primarily describes administrative and procedural details, such as protocol consent, baseline symptom review, and logistical arrangements. No specific adverse events are mentioned in the text."
fc68f402183b853a44935936ce8a3be4,12/26/18,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The text states that abnormal labs and symptoms were noted but none were clinically significant unless otherwise documented in the physician-reviewed AE sheet. Since no specific adverse events are described in the note, no data can be extracted for the requested format."
fc68f402183b853a44935936ce8a3be4,2/5/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific AEs are described in the text, the output will reflect the absence of extractable AEs.

```json
[]
```"
fc68f402183b853a44935936ce8a3be4,2/19/19,"```json
[
  {
    ""AE_Term"": ""Elevated ALT"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Elevated AST"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Elevated TSH"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
fc68f402183b853a44935936ce8a3be4,3/5/19,"```json
[
  {
    ""AE Term"": ""Increased ALT"",
    ""Grade"": ""Not specified (assume Grade 2 or higher based on intervention)"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Possible (e.g., herbal supplements or other medications)""
    }
  },
  {
    ""AE Term"": ""Increased AST"",
    ""Grade"": ""Not specified (assume Grade 2 or higher based on intervention)"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Possible (e.g., herbal supplements or other medications)""
    }
  }
]
``` 

### Notes:
1. The adverse events ""Increased ALT"" and ""Increased AST"" were identified as new or worsening since they led to the holding of the investigational drug (m7824) and the initiation of prednisone treatment. These were not described as baseline symptoms.
2. The grade of the events is not explicitly mentioned in the note, but the intervention (holding the drug and starting prednisone) suggests at least Grade 2 or higher.
3. Attribution to the investigational drug (m7824) is marked as ""Probable"" based on the clinical context, while other potential causes (e.g., herbal supplements or medications) are also considered ""Possible.""
4. No other new or worsening adverse events were documented in the note."
fc68f402183b853a44935936ce8a3be4,3/13/19,"Based on the provided clinical note, there is no explicit mention of specific adverse events (AEs) or their details (e.g., AE term, grade, or attribution). The note only states that ""all adverse events [were] reviewed and discussed with Dr. Strauss,"" but it does not provide the actual AEs or their characteristics.

If you have additional clinical notes or documentation that explicitly lists the adverse events, I can assist in extracting and formatting them as requested. Please provide more detailed information."
fc68f402183b853a44935936ce8a3be4,3/18/19,"```json
[]
``` 

**Explanation:** Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that abnormal labs and clinical symptoms were observed but none were considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted in the physician and RN notes. Since no specific new or worsening adverse events are documented, the output is an empty JSON list."
fc68f402183b853a44935936ce8a3be4,4/1/19,"```json
[]
``` 

**Explanation:**
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment with M7824. The note primarily discusses the patient's history of transaminitis (which was already known and attributed to the study drug, leading to the drug being on hold) and the current treatment plan. There is no mention of new or worsening symptoms or adverse events in the text."
fc68f402183b853a44935936ce8a3be4,4/16/19,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Additionally, the patient is described as feeling ""very well"" and active in all activities of daily living (ADLs). There is no documentation of any new or worsening symptoms or adverse events that emerged after the start of treatment."
fc68f402183b853a44935936ce8a3be4,5/1/19,"```json
[
  {
    ""AE Term"": ""Dyspnea on exertion"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Pericardial effusion (slight increase)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
fc68f402183b853a44935936ce8a3be4,5/13/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events (AEs) explicitly described. The note mentions abnormal labs and clinical symptoms but states that none are considered clinically significant, serious adverse events (SAEs), or adverse events of special interest (AESIs) unless otherwise noted. Additionally, the patient reports physical trauma from being hit by baseballs, but this is unrelated to the treatment and does not qualify as a treatment-emergent AE. The patient also states that their dyspnea has improved, indicating no worsening of this symptom. Therefore, no new or worsening AEs attributable to the treatment were identified in the text."
fc68f402183b853a44935936ce8a3be4,5/28/19,"```json
[]
```

### Explanation:
The clinical note explicitly states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Additionally, the patient reports feeling overall well and that their dyspnea has improved. There is no mention of new or worsening adverse events in the provided text. Therefore, no adverse events meet the criteria for extraction."
95a25c446c0420eb661d768b5d097f1b,3/3/20,"```json
[
  {
    ""AE Term"": ""Fever"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Cough"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Wheezing"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
95a25c446c0420eb661d768b5d097f1b,3/13/20,"```json
[]
``` 

Explanation: The provided clinical note does not mention any new or worsening adverse events. It primarily describes the patient's visit, instructions provided, and follow-up plans. There is no documentation of symptoms or adverse events that emerged or worsened after the start of treatment."
95a25c446c0420eb661d768b5d097f1b,3/17/20,"```json
[
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: NSH-IL12)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Cough"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: NSH-IL12)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
``` 

### Explanation:
- **Dyspnea** and **Cough** were noted as ongoing symptoms, but their worsening is implied by the mention of ""mediastinal progression"" on re-staging scans, which is attributed to these symptoms. This suggests they have worsened since baseline.
- Both events are graded as **Grade 2** based on the need for symptom management with albuterol nebulizer and benzonatate.
- Attribution is marked as **""Probable"" for Disease Related** due to the mediastinal progression, and **""Unlikely"" for Drug/Device Intervention** (NSH-IL12) since the progression is attributed to disease rather than the study drug."
95a25c446c0420eb661d768b5d097f1b,3/19/20,"```json
[
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
``` 

### Notes:
1. The adverse event ""dyspnea"" is mentioned as ""increased dyspnea,"" indicating worsening after treatment began.
2. The grade of the adverse event is not explicitly provided in the note, so it is marked as ""Not specified.""
3. Attribution is based on the context provided:
   - The dyspnea is likely related to disease progression (""disease progression with associated increased dyspnea"").
   - There is no indication that the dyspnea is related to the drug/device intervention (m7824).
   - No other contributing factors are mentioned."
95a25c446c0420eb661d768b5d097f1b,3/23/20,"```json
[]
```

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) documented. The patient was discharged post-palliative radiation therapy and tolerated the procedure well, with no new complaints reported. Therefore, no AEs meet the criteria for extraction."
95a25c446c0420eb661d768b5d097f1b,3/24/20,"```json
[
  {
    ""AE Term"": ""Anorexia"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Definite (related to medication: morphine)""
    }
  }
]
```"
95a25c446c0420eb661d768b5d097f1b,4/7/20,"```json
[
  {
    ""AE Term"": ""Congestion"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Cough with clear sputum production"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Post-tussive nausea and vomiting"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Dysphagia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anorexia"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Urinary tract infection symptoms"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
95a25c446c0420eb661d768b5d097f1b,4/21/20,"```json
[
  {
    ""AE Term"": ""Pneumonitis"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Ground glass opacities (radiologic finding)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Low potassium (hypokalemia)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Low magnesium (hypomagnesemia)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Low hemoglobin (anemia)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hematuria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
95a25c446c0420eb661d768b5d097f1b,5/1/20,"```json
[
  {
    ""AE Term"": ""Seizure"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Brain metastasis (right parietal lobe, 2x2 cm)"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
95a25c446c0420eb661d768b5d097f1b,5/14/20,"```json
[
  {
    ""AE Term"": ""Chest tightness"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Brain metastasis"",
    ""Grade"": 4,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
465c8bdb1a94aa4ec6e2ac2b230c1caa,7/30/19,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) documented after the start of treatment. All the symptoms listed (tumor pain, lymphocyte count decreased, anemia, and hyperglycemia) are explicitly noted as baseline symptoms or conditions that were present before treatment. Therefore, no new or worsening AEs can be extracted."
bf11e3cd44670a1d3c6a93e5801a9aa5,12/4/18,"```json
[]
```

**Explanation**: Based on the provided clinical note, all adverse events listed are baseline symptoms (e.g., cough, hypertension, edema, dyspnea, etc.) and are explicitly stated as either ""not related to disease"" or ""RELATED to disease"" at baseline. There is no mention of any new or worsening adverse events after the start of treatment. Therefore, the output is an empty list."
bf11e3cd44670a1d3c6a93e5801a9aa5,12/18/18,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician or RN notes."" However, no specific AEs are described in this text. Therefore, the output will be an empty JSON list, as no extractable AEs meet the criteria.

```json
[]
```"
bf11e3cd44670a1d3c6a93e5801a9aa5,12/31/18,"```json
[]
```

**Explanation**: The provided clinical note does not mention any new or worsening adverse events. It primarily discusses the patient's missed visit due to travel plans and their awareness of the next scheduled appointment. There is no mention of symptoms, adverse events, or changes in the patient's condition."
bf11e3cd44670a1d3c6a93e5801a9aa5,1/15/19,"```json
[]
```

**Explanation:**
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. It states that ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician or RN notes."" Without specific details about the AEs, their grades, or attribution, no extractable AEs can be identified from this note."
bf11e3cd44670a1d3c6a93e5801a9aa5,1/29/19,"```json
[]
```

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that ""abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific new or worsening AEs are described in the text, there are no events to extract."
bf11e3cd44670a1d3c6a93e5801a9aa5,2/12/19,"```json
[]
```

**Explanation:**
The clinical note explicitly states: ""No new adverse events reported at this time point."" Therefore, there are no new or worsening adverse events to extract from this note."
bf11e3cd44670a1d3c6a93e5801a9aa5,2/22/19,"```json
[]
``` 

Explanation: The provided clinical note does not mention any new or worsening adverse events. It primarily discusses logistical changes to the patient's protocol schedule and does not include any information about symptoms, adverse events, or changes in the patient's condition after the start of treatment."
bf11e3cd44670a1d3c6a93e5801a9aa5,2/26/19,"```json
[
  {
    ""AE Term"": ""Headache"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
bf11e3cd44670a1d3c6a93e5801a9aa5,3/12/19,"```json
[
  {
    ""AE Term"": ""Cough"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Sleep disturbance due to coughing"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
bf11e3cd44670a1d3c6a93e5801a9aa5,3/28/19,"```json
[
  {
    ""AE Term"": ""Intermittent supraventricular tachycardia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
bf11e3cd44670a1d3c6a93e5801a9aa5,4/9/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events (AEs) explicitly described. The note mentions abnormal labs and clinical symptoms but states that none are clinically significant, serious adverse events (SAEs), or adverse events of special interest (AESIs) unless otherwise noted. Additionally, the patient is reported as asymptomatic at the time of the visit. Therefore, no new or worsening AEs can be extracted from this note."
bf11e3cd44670a1d3c6a93e5801a9aa5,4/23/19,"```json
[
  {
    ""AE Term"": ""Dyspnea on exertion"",
    ""Grade"": ""Not specified (assume Grade 1 unless otherwise clarified)"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Explanation:
1. **AE Term**: ""Dyspnea on exertion"" was explicitly mentioned as a patient complaint (""c/o increased dyspnea on exertion""). This suggests it is a new or worsening symptom.
2. **Grade**: The grade was not specified in the note. By default, it is assumed to be Grade 1 unless further clarification is provided.
3. **Attribution**:
   - **Disease Related?**: Marked as ""Possible"" because dyspnea could be related to the underlying disease.
   - **Drug/Device Intervention? (Intervention: m7824)**: Marked as ""Possible"" because the study drug could potentially contribute to this symptom.
   - **Related to Other?**: Marked as ""Unlikely"" since no other contributing factors were mentioned in the note.

If additional information about the grade or attribution becomes available, the output should be updated accordingly."
bf11e3cd44670a1d3c6a93e5801a9aa5,4/26/19,"```json
[]
```

**Explanation:**  
The provided clinical note does not contain specific information about new or worsening adverse events. It only mentions that adverse events were reviewed by the investigator for the visit date (4.9.19) but does not list or describe any specific adverse events, their grades, or attributions. Therefore, no data can be extracted based on the criteria provided."
bf11e3cd44670a1d3c6a93e5801a9aa5,4/30/19,"```json
[]
```

### Explanation:
The clinical note provided does not explicitly mention any **new or worsening adverse events** that emerged after the start of treatment. The note states that ""abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Additionally, the patient's dyspnea on exertion is mentioned, but it is not explicitly described as new or worsening, and it appears to be a baseline symptom since there is no indication that it emerged or worsened after treatment. Therefore, no adverse events meet the criteria for extraction."
aa49b14fb81ff7e0f080562cff98ee13,11/19/19,"```json
[]
``` 

**Explanation**:  
The clinical note provided does not document any new or worsening adverse events (AEs) that emerged after the start of treatment with M7824. All symptoms mentioned (e.g., GERD, increased serum creatinine, hypothyroidism, tinnitus) are explicitly described as baseline findings and are attributed to prior treatments or conditions unrelated to the investigational drug. Therefore, no new or worsening AEs were identified for extraction."
aa49b14fb81ff7e0f080562cff98ee13,12/3/19,"```json
[
  {
    ""AE_Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
aa49b14fb81ff7e0f080562cff98ee13,12/17/19,"```json
[
  {
    ""AE_Term"": ""Epistaxis"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  },
  {
    ""AE_Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
```"
aa49b14fb81ff7e0f080562cff98ee13,1/2/20,"```json
[
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
aa49b14fb81ff7e0f080562cff98ee13,1/14/20,"```json
[
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Decreased hemoglobin"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
aa49b14fb81ff7e0f080562cff98ee13,1/28/20,"```json
[
  {
    ""AE Term"": ""ALT increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""AST increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""TSH increased"",
    ""Grade"": ""Not graded (requires clinical interpretation)"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible (e.g., pre-existing thyroid condition)""
    }
  }
]
```"
aa49b14fb81ff7e0f080562cff98ee13,2/11/20,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events reported. The patient mentions improved epistaxis (less frequent nosebleeds) and improved fatigue (no longer needing naps, able to work additional hours, and walking for exercise). These symptoms are improving rather than worsening, and no new adverse events are described. Therefore, the output is an empty JSON list."
aa49b14fb81ff7e0f080562cff98ee13,2/25/20,"```json
[
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Decreased libido"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
aa49b14fb81ff7e0f080562cff98ee13,3/10/20,"```json
[
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Decreased libido"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Possible""
    }
  }
]
```"
aa49b14fb81ff7e0f080562cff98ee13,3/24/20,"```json
[
  {
    ""AE Term"": ""Headache"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Rhinorrhea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""TSH elevation"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
aa49b14fb81ff7e0f080562cff98ee13,3/31/20,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged after the start of treatment with M7824. The note states that ""adverse events captured are current per last patient interaction,"" but it does not provide specific details about the AEs or their grades, attributions, or whether they are new or worsening.

If you have additional clinical notes or documentation that explicitly lists adverse events, I can assist in extracting and formatting them. For now, the output is as follows:

```json
[]
```

If you can provide more detailed information or another section of the clinical notes, I can revisit and extract the relevant AEs."
4fd9ca376efebbf6ccc1cc88457d025c,6/9/20,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events documented after the start of treatment with M7824. All symptoms listed are baseline findings and were present before treatment initiation. Therefore, no adverse events meet the criteria for extraction."
4fd9ca376efebbf6ccc1cc88457d025c,6/9/20,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events documented after the start of treatment with M7824. All symptoms listed are baseline findings and were present before treatment initiation. Therefore, no adverse events meet the criteria for extraction."
4fd9ca376efebbf6ccc1cc88457d025c,6/9/20,"```json
[
  {
    ""AE Term"": ""Pruritic hives"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,6/23/20,"```json
[
  {
    ""AE Term"": ""Vaginal bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Infusion reaction"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,7/7/20,"```json
[
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Shortness of breath"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,7/21/20,"```json
[
  {
    ""AE Term"": ""Vaginal bleeding"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,8/4/20,"```json
[
  {
    ""AE Term"": ""Vaginal bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,8/18/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash Maculo-papular"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,9/1/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Rash Maculo-papular"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Neuralgia-sciatic like shooting pain, radiating to left thigh"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""No""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,9/15/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Rash Maculo-papular"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""No""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,9/29/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Rash Maculo-papular"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,10/13/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Rash Maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""No""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,10/27/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Rash Maculo-papular (Right Forearm and Left Anterior Chest)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""No""
    }
  },
  {
    ""AE Term"": ""Rash Maculopapular (Lichenoid Dermatitis)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""No""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,11/11/20,"```json
[
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,11/24/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable (M7824)"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash Maculo-papular (Right Forearm and Left Anterior Chest)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible (M7824)"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable (M7824)"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash Maculopapular-Lichenoid Dermatitis (Left Leg and Chest)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible (M7824)"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria (Facial Areas)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated (M7824)"",
      ""Related to Other?"": ""Probable (Skin reaction to surgical masks)""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,12/8/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Skin Ulceration"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder - partial tendon rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,12/8/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder - partial tendon rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Allergic reaction: pruritus and burning on extremities where cream applied"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,12/22/20,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Allergic Reaction: Pruritus and Burning on Extremities"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Rash Maculopapular-Lichenoid Dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial Areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and Connective Tissue Disorder-Partial Tendon Rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,1/5/21,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage, intermittent"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable (M7824)"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage, intermittent"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable (M7824)"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible (M7824)"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated (M7824)"",
      ""Related to Other?"": ""Probable (Skin reaction to surgical masks)""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder-partial tendo rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable (Daily Activity)""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,1/19/21,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder - partial tendon rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,1/21/21,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage, intermittent"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Allergic reaction: pruritus and burning on extremities where cream is applied"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage, intermittent"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder-partial tendo rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,2/2/21,"```json
[
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder-partial tendo rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,2/16/21,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder-partial tendo rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,3/2/21,"```json
[
  {
    ""AE Term"": ""Edema limbs"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable (Dietary indiscretions)""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Probable (Triamcinolone)""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,3/2/21,"```json
[
  {
    ""AE Term"": ""Edema limbs"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,3/16/21,"```json
[
  {
    ""AE Term"": ""Edema Limbs"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder-partial tendo rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,3/17/21,"```json
[
  {
    ""AE Term"": ""Edema limbs"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,3/30/21,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Edema Limbs"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder-partial tendon rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,6/22/21,"```json
[
  {
    ""AE Term"": ""Vaginal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Edema Limbs"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anal Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Rash maculopapular-lichenoid dermatitis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Urticaria-Facial areas"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and connective tissue disorder-partial tendo rupture"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Platelet Count decreased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,9/21/21,"```json
[
  {
    ""AE Term"": ""Urticaria"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated (M7824)"",
      ""Related to Other?"": ""Probable (Skin reaction to surgical masks)""
    }
  },
  {
    ""AE Term"": ""Platelet count decreased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable (M7824)"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,12/14/21,"```json
[
  {
    ""AE_Term"": ""Platelet count decreased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""Unrelated""
    },
    ""Start_Date"": ""09/15/2020"",
    ""Intervention"": ""No"",
    ""Comments"": ""Not SAE or AESI""
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,3/8/22,"```json
[
  {
    ""AE_Term"": ""Platelet count decreased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug/Device_Intervention"": ""Probable"",
      ""Related_to_Other"": ""No""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,5/31/22,"```json
[
  {
    ""AE Term"": ""Serum amylase increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""N/A""
    }
  },
  {
    ""AE Term"": ""Thromboembolic event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,9/6/22,"```json
[
  {
    ""AE Term"": ""Serum Amylase Increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""N/A""
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable (Implantable Port)""
    }
  },
  {
    ""AE Term"": ""Platelet count decreased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""N/A""
    }
  }
]
```"
4fd9ca376efebbf6ccc1cc88457d025c,12/6/22,"```json
[
  {
    ""AE Term"": ""Creatinine increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Thromboembolic event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable (Implantable Port)""
    }
  },
  {
    ""AE Term"": ""Anal hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Edema limbs"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Venous insufficiency""
    }
  }
]
```"
f93819c38f7ca8f77469ee9f53fce1de,3/11/19,"```json
[]
```

**Explanation**: The clinical note provided does not mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily discusses the patient being taken off the study due to not having the correct HLA type, and there is no mention of symptoms or adverse events. Therefore, the output is an empty list."
f93819c38f7ca8f77469ee9f53fce1de,4/8/19,"```json
[]
``` 

**Explanation**: The provided clinical note does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. It primarily describes protocol documentation, baseline information, and procedural details. No specific adverse events are documented in the text."
f93819c38f7ca8f77469ee9f53fce1de,4/10/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, all adverse events listed (Anxiety, Constipation, Pain, Abdominal soft tissue necrosis) are described as ongoing or having an onset prior to treatment initiation. There is no indication in the note that any of these events are new or have worsened after the start of treatment with m7824. Therefore, no new or worsening adverse events are extracted."
f93819c38f7ca8f77469ee9f53fce1de,4/25/19,"```json
[
  {
    ""AE Term"": ""Nausea"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Vomiting"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hypercalcemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unrelated"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,11/20/18,"```json
[
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Generalized muscle weakness"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,12/4/18,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly list any new or worsening adverse events (AEs) that emerged after the start of treatment. It mentions abnormal labs and symptoms but states that none are clinically significant unless otherwise noted in the physician-reviewed AE sheet. Additionally, the note directs the reader to the Free Text Progress Note for updated AEs, which is not included in the provided text. Therefore, no extractable AEs are present in the given information."
4013ce1eb4e04dc53415c02629dc6a36,12/18/18,"```json
[]
```

**Explanation**: Based on the provided clinical note, there are no explicit mentions of new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet."" Additionally, the patient is reported to be ""feeling much improved since diagnosed with adrenal insufficiency and started on steroid course."" Without specific details of new or worsening AEs in the text, no events can be extracted."
4013ce1eb4e04dc53415c02629dc6a36,12/31/18,"```json
[]
``` 

**Explanation**: The provided clinical note does not mention any new or worsening adverse events (AEs). It only discusses the patient's decision not to attend the protocol visit for week 33 due to personal reasons (family holiday plans). There is no mention of symptoms, adverse events, or changes in the patient's condition that could be mapped to CTCAE terminology."
4013ce1eb4e04dc53415c02629dc6a36,1/15/19,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly list any new or worsening adverse events (AEs). It mentions abnormal labs and symptoms but states that none are clinically significant unless noted in the physician-reviewed AE sheet. Additionally, the note refers to updated AEs in the Free Text Progress Note, which is not included in the provided text. Therefore, no extractable AEs are present in this document."
4013ce1eb4e04dc53415c02629dc6a36,1/29/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific AEs are described in the text, the output will reflect the absence of extractable AEs.

```json
[]
```"
4013ce1eb4e04dc53415c02629dc6a36,2/12/19,"```json
[]
```

**Explanation:**
The clinical note explicitly states: ""No new adverse events to report at this time point."" Therefore, there are no new or worsening adverse events to extract from this note."
4013ce1eb4e04dc53415c02629dc6a36,2/26/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that abnormal labs and clinical symptoms were observed but none were deemed clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted in physician and RN notes. Since no specific new or worsening adverse events are documented, the output is an empty JSON list."
4013ce1eb4e04dc53415c02629dc6a36,3/12/19,"```json
[]
``` 

### Explanation:
After reviewing the clinical note, there are no **new or worsening adverse events** reported. The patient continues to experience ""left ear fullness,"" which is explicitly noted as residual from a prior upper respiratory infection (URI) episode documented on 02/21/19, predating the treatment. Additionally, the central adrenal insufficiency is a known condition for which the patient is already on oral steroid treatment, and the study drug (M7824) remains on hold due to this pre-existing condition. No other new complaints or adverse events are mentioned in the note."
4013ce1eb4e04dc53415c02629dc6a36,3/26/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events reported. The patient has no new complaints at this time, and her status is described as stable. The central adrenal insufficiency and oral steroid treatment (hydrocortisone) are ongoing issues but were already present prior to this visit and are not described as worsening. Therefore, no new or worsening adverse events are identified for extraction."
4013ce1eb4e04dc53415c02629dc6a36,3/28/19,"Based on the provided clinical note, there is no specific mention of new or worsening adverse events (AEs) or detailed descriptions of symptoms. The note primarily discusses a correction to prior records of AEs without providing explicit information about the AEs themselves. Therefore, no extractable AEs can be identified from this text.

If additional clinical notes or details are provided that include descriptions of new or worsening AEs, I can assist in extracting and formatting them accordingly."
4013ce1eb4e04dc53415c02629dc6a36,4/9/19,"```json
[]
``` 

**Explanation:**  
The provided clinical note does not mention any new or worsening adverse events. It primarily discusses logistical changes to the patient's protocol visit schedule, the continuation of the study drug hold (M7824), and the patient's stable status. There are no references to symptoms or adverse events that emerged or worsened after the start of treatment."
4013ce1eb4e04dc53415c02629dc6a36,4/23/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events (AEs) documented. The note explicitly states that abnormal labs and clinical symptoms were noted but none were clinically significant, serious adverse events (SAEs), or adverse events of special interest (AESIs). Additionally, the patient reports improvement in fatigue, resolution of ear fullness, and resolution of myalgia, which indicates no new or worsening symptoms. Therefore, no AEs meet the criteria for extraction."
4013ce1eb4e04dc53415c02629dc6a36,6/4/19,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no new or worsening adverse events explicitly documented. The note mentions abnormal labs and clinical symptoms but states that none are clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted. Additionally, the patient's increased appetite and weight gain are mentioned, but these are attributed to her use of a dietary supplement, not the intervention (m7824). Therefore, no adverse events meet the criteria for extraction."
4013ce1eb4e04dc53415c02629dc6a36,7/2/19,"```json
[
  {
    ""AE Term"": ""Increased appetite"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Weight gain"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Depression"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Night sweats"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Headache (tension-type)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,8/27/19,"```json
[
  {
    ""AE Term"": ""Night sweats"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,10/8/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that ""abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific adverse events are described as new or worsening, the output is an empty JSON list."
4013ce1eb4e04dc53415c02629dc6a36,10/22/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific AEs are described in the text, the output will reflect the absence of extractable AEs.

```json
[]
```"
4013ce1eb4e04dc53415c02629dc6a36,11/5/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events (AEs) explicitly mentioned. The note states that ""abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes,"" and ""patient with no new complaints this visit."" Therefore, no AEs meet the criteria for extraction."
4013ce1eb4e04dc53415c02629dc6a36,11/19/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events (AEs) documented. The note explicitly states that ""abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Additionally, the patient reported ""no new complaints this visit"" and stated she has been ""feeling well since previous infusion."" Therefore, no AEs meet the criteria for extraction."
4013ce1eb4e04dc53415c02629dc6a36,12/17/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events (AEs) documented. The note explicitly states that ""Patient with no new complaints this visit, states she has been feeling well since previous infusion."" Additionally, abnormal labs and clinical symptoms were noted but deemed ""none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Therefore, no AEs meet the criteria for extraction."
4013ce1eb4e04dc53415c02629dc6a36,12/31/19,"```json
[
  {
    ""AE Term"": ""Dry mouth"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Dry eyes"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Rash"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Itching"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Pulmonary embolism"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,1/14/20,"```json
[
  {
    ""AE Term"": ""Dry mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Dry eyes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,1/28/20,"```json
[
  {
    ""AE Term"": ""Dry mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dry eyes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,2/11/20,"```json
[
  {
    ""AE Term"": ""Dry mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Dry eyes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,3/10/20,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. It states that abnormal labs and clinical symptoms were noted but none were clinically significant, serious adverse events (SAEs), or adverse events of special interest (AESIs) unless otherwise noted in physician and RN notes. Since no specific AEs are described in the text, there are no events to extract based on the criteria provided."
4013ce1eb4e04dc53415c02629dc6a36,3/24/20,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no specific new or worsening adverse events (AEs) explicitly mentioned. The note states that abnormal labs and clinical symptoms were observed but none were deemed clinically significant, serious adverse events (SAEs), or adverse events of special interest (AESIs) unless otherwise noted in physician and RN notes. Since no specific AEs are described in the text, there is no data to extract."
4013ce1eb4e04dc53415c02629dc6a36,6/17/20,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Not specified"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Not specified"",
      ""Related to Other?"": ""Not specified""
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Not specified"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Not specified"",
      ""Related to Other?"": ""Not specified""
    }
  }
]
``` 

### Notes:
1. The clinical note specifies the addition of ""Adrenal Insufficiency"" and ""Hypothyroidism"" as new adverse events, but it does not provide specific grades or attribution details. These fields are marked as ""Not specified.""
2. The AE ""Hypophysitis, Gr. 2"" was explicitly removed and is therefore excluded from the output.
3. If additional context or details about attribution or grades are available in other documentation, they should be incorporated into the output."
4013ce1eb4e04dc53415c02629dc6a36,7/28/20,"```json
[]
```

**Explanation**: The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. It states that ""abnormal labs and clinical symptoms noted but none clinically significant/SAE/AESI unless otherwise noted in physician and RN notes."" Since no specific new or worsening AEs are described in this note, there are no AEs to extract based on the provided criteria."
4013ce1eb4e04dc53415c02629dc6a36,10/20/20,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Ear and Labyrinth Disorders  Other: Fullness/Congestion Left Ear"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and Connective Tissue Disorder  Other: TMJ Symptoms, Left Jaw"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": null
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,12/1/20,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Ear and Labyrinth Disorders  Other: fullness/congestion left ear"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and Connective Tissue Disorder  Other: TMJ symptoms, Left jaw"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": null
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,12/22/20,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Ear and Labyrinth Disorders  Other: Fullness/Congestion Left Ear"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and Connective Tissue Disorder  Other: TMJ Symptoms, Left Jaw"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": null
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,1/5/21,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Ear and Labyrinth Disorders  Other: fullness/congestion left ear"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and Connective Tissue Disorder  Other: TMJ symptoms, Left jaw"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,1/19/21,"```json
[
  {
    ""AE Term"": ""ORAL HEMORRHAGE"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""FATIGUE"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""HYPOMAGNESEMIA"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,2/2/21,"```json
[]
```

**Explanation**: The provided clinical note does not mention any new or worsening adverse events. The text primarily discusses the patient's communication about missing a scheduled appointment due to inclement weather. There is no mention of symptoms, adverse events, or any clinical findings that could be mapped to CTCAE terminology."
4013ce1eb4e04dc53415c02629dc6a36,2/16/21,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Hypomagnesemia"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,3/2/21,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Ear and Labyrinth Disorders  Other: Fullness/Congestion Left Ear"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and Connective Tissue Disorder  Other: TMJ Symptoms, Left Jaw"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,3/16/21,"```json
[
  {
    ""AE Term"": ""Dry eyes"",
    ""Grade"": ""Not yet graded"",
    ""Attribution"": {
      ""Disease Related?"": ""Not yet determined"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Not yet determined"",
      ""Related to Other?"": ""Not yet determined""
    }
  }
]
``` 

### Notes:
- The clinical note mentions ""increasing dry eyes,"" which suggests this is a **worsening adverse event**. However, the grade and attribution are not explicitly provided in the note and are pending review with the Principal Investigator (PI).
- No other specific adverse events are detailed in the provided text. The note refers to ""several AEs"" but does not list them explicitly. These would need to be reviewed in the prescriber note mentioned in the text for further extraction."
4013ce1eb4e04dc53415c02629dc6a36,4/5/21,"Based on the provided clinical note, there is no mention of specific adverse events (AEs) that emerged or worsened after the start of treatment. The note primarily discusses the patient's absence from a scheduled protocol visit due to COVID-19 travel precautions and ongoing treatment hold. There are no details about new or worsening symptoms or adverse events in the text.

If you have additional clinical notes or sections that include information about adverse events, please provide them, and I will assist in extracting the relevant data."
4013ce1eb4e04dc53415c02629dc6a36,4/27/21,"```json
[
  {
    ""AE Term"": ""Dry eye"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Not specified"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Not specified"",
      ""Related to Other?"": ""Not specified""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Not specified"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Not specified"",
      ""Related to Other?"": ""Not specified""
    }
  }
]
```

### Notes:
1. The clinical note does not specify the grade or attribution for the adverse events (AEs) of ""dry eye"" and ""fatigue."" These details would need to be clarified after review with the Principal Investigator (PI), as mentioned in the note.
2. Both ""dry eye"" and ""fatigue"" are listed as AEs that led to a treatment hold, suggesting they are new or worsening since the start of treatment.
3. If additional context or clarification is provided, the output can be updated accordingly."
4013ce1eb4e04dc53415c02629dc6a36,5/4/21,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Acneiform Rash"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": null
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": null
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,7/20/21,"```json
[]
``` 

Explanation: Based on the clinical note provided, there are no **new or worsening adverse events** reported during this follow-up visit. The note explicitly states, ""The patient does not have any new adverse events,"" and the protocol documentation does not indicate any worsening of previously reported adverse events. Therefore, the output is an empty JSON list."
4013ce1eb4e04dc53415c02629dc6a36,10/19/21,"```json
[
  {
    ""AE Term"": ""Dry eye"",
    ""Grade"": ""To be determined by PI"",
    ""Attribution"": {
      ""Disease Related?"": ""To be determined by PI"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""To be determined by PI"",
      ""Related to Other?"": ""To be determined by PI""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": ""To be determined by PI"",
    ""Attribution"": {
      ""Disease Related?"": ""To be determined by PI"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""To be determined by PI"",
      ""Related to Other?"": ""To be determined by PI""
    }
  }
]
``` 

### Notes:
- The clinical note specifies that adverse events (AEs) will be reviewed with the Principal Investigator (PI) to determine grades and attributions. Therefore, placeholders (""To be determined by PI"") are used for these fields.
- Both ""dry eye"" and ""fatigue"" are listed as AEs leading to a treatment hold, suggesting they are new or worsening since the start of treatment."
4013ce1eb4e04dc53415c02629dc6a36,10/20/21,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,12/7/21,"```json
[]
``` 

**Explanation:**  
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged or worsened after the start of treatment. It primarily discusses the patient's progression of disease based on imaging and the plan to restart protocol treatment. No specific symptoms or adverse events are described in the text. Therefore, the output is an empty JSON list."
4013ce1eb4e04dc53415c02629dc6a36,12/9/21,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Diarrhea"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Back Pain"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,12/21/21,"```json
[]
``` 

**Explanation:**  
The provided clinical note does not explicitly mention any new or worsening adverse events (AEs). It states that adverse events will be captured and recorded after review with the Principal Investigator (PI) for grades and attributions, but no specific AEs are documented in the text. Therefore, no AEs can be extracted based on the given information."
4013ce1eb4e04dc53415c02629dc6a36,12/23/21,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Hot Flashes"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Possible""
    }
  },
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Flatulence"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Ear and Labyrinth Disorders  Other: Fullness/Congestion Left Ear"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Musculoskeletal and Connective Tissue Disorder  Other: TMJ Symptoms, Left Jaw"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Alk Phos Increased"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,1/4/22,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events (AEs) documented. The note explicitly states that the patient has ""no new complaints at this time,"" and adverse events will be captured after review with the Principal Investigator (PI). Therefore, no AEs can be extracted from this text."
4013ce1eb4e04dc53415c02629dc6a36,1/6/22,"```json
[
  {
    ""AE Term"": ""Adrenal Insufficiency"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Hypothyroidism"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Thromboembolic Event"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Weight Gain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Oral Hemorrhage"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Dry Mouth"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Flatulence"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""Dry Eye"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
4013ce1eb4e04dc53415c02629dc6a36,1/18/22,"```json
[]
```

**Explanation:**
The clinical note provided does not explicitly document any new or worsening adverse events (AEs) that emerged after the start of treatment. While the note mentions disease progression as determined by the CT scan, this is a natural progression of the underlying condition and not explicitly described as a treatment-emergent AE. Additionally, the note states that AEs will be captured and recorded after review with the Principal Investigator (PI) for grading and attribution, suggesting that specific AEs have not yet been formally documented or assessed in this note."
4013ce1eb4e04dc53415c02629dc6a36,1/21/22,"```json
[
  {
    ""AE Term"": ""ADRENAL INSUFFICIENCY"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""HYPOTHYROIDISM"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""THROMBOEMBOLIC EVENT"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""WEIGHT GAIN"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""FATIGUE"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""CONSTIPATION"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""ORAL HEMORRHAGE"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""DRY MOUTH"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""FLATULENCE"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Unrelated"",
      ""Related to Other?"": ""Probable""
    }
  },
  {
    ""AE Term"": ""SERUM AMYLASE INCREASED"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  },
  {
    ""AE Term"": ""DRY EYE"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unrelated"",
      ""Drug/Device Intervention?"": ""Possible"",
      ""Related to Other?"": ""None""
    }
  }
]
```"
fd204329b6f420abfec04e8269fee41e,7/9/19,"```json
[]
``` 

**Explanation**:  
The clinical note provided does not document any new or worsening adverse events (AEs) that emerged after the start of treatment. All symptoms and conditions listed are either baseline symptoms (e.g., dyspnea on exertion, cough, pelvic pain) or laboratory abnormalities (e.g., hyperglycemia, anemia, AST/ALT increase, proteinuria, hematuria, hypomagnesemia) that are explicitly noted as unrelated to the disease or pre-existing before treatment. No new or worsening AEs attributable to the treatment (m7824) or other causes are described in the note."
fd204329b6f420abfec04e8269fee41e,7/24/19,"```json
[
  {
    ""AE Term"": ""Vaginal bleeding"",
    ""Grade"": ""3"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Dyspnea"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hypoxia"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Tachycardia"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": ""3"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hyponatremia"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hypokalemia"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Hypomagnesemia"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Fatigue"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Decreased appetite"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
fd204329b6f420abfec04e8269fee41e,8/7/19,"```json
[
  {
    ""AE Term"": ""Vaginal bleeding"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
6670265bba3f83c1294410a268d3e503,10/22/19,"Based on the provided clinical note, there is no mention of any adverse events (AEs) that emerged or worsened after the start of treatment. The note primarily discusses the screening visit, protocol information, and procedural steps (e.g., HLA testing, HPV testing, consent review). There is no documentation of symptoms, adverse events, or treatment-related issues in the text.

As a result, the output is an empty JSON list:

```json
[]
```"
6670265bba3f83c1294410a268d3e503,10/31/19,"```json
[]
```

**Explanation**: The provided clinical note does not mention any new or worsening adverse events (AEs). The note primarily discusses the patient being taken off the study due to not meeting the HLA A0201 eligibility criteria. There is no mention of symptoms, adverse events, or their attribution to disease, drug/device intervention, or other causes."
6670265bba3f83c1294410a268d3e503,11/5/19,"```json
[]
```

### Explanation:
After reviewing the clinical note, all adverse events listed are baseline symptoms documented prior to the start of treatment. No new or worsening adverse events are mentioned in the note after the initiation of treatment. Therefore, the output is an empty JSON list."
6670265bba3f83c1294410a268d3e503,11/19/19,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly list any new or worsening adverse events. It mentions ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet."" Without specific details about the adverse events, their grades, or attributions, no new or worsening AEs can be extracted from this text."
6670265bba3f83c1294410a268d3e503,12/3/19,"```json
[
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": ""Not specified (assume Grade 2 based on clinical context and dose hold)"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Increased liver enzymes"",
    ""Grade"": ""Not specified (assume Grade 2 based on clinical context and dose hold)"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
6670265bba3f83c1294410a268d3e503,12/9/19,"```json
[
  {
    ""AE Term"": ""Right hepatic lesion intralesional bleed"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Tumor hemorrhage"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
6670265bba3f83c1294410a268d3e503,12/17/19,"```json
[
  {
    ""AE Term"": ""Constipation"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Exertional dyspnea"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Disease progression"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Definite"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Bleeding risk"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
``` 

### Notes:
1. **Constipation** and **exertional dyspnea** were explicitly mentioned as ongoing issues, but since the note does not clarify whether they were baseline symptoms or worsened during treatment, they are conservatively included as new or worsening AEs.
2. **Disease progression** is a clear worsening condition and is attributed primarily to the disease itself.
3. **Bleeding risk** is mentioned as a safety concern and is included as a new AE, likely related to both disease and treatment.
4. Grades and attributions are inferred based on the clinical context provided in the note."
ccecd2b9caceb75e156d158ef7513799,12/24/18,"```json
[]
```

**Explanation**: The provided clinical note does not explicitly list any new or worsening adverse events (AEs). It mentions ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet"" and refers to a ""Free Text Progress Note for updated AE's."" However, no specific AEs are detailed in the text provided. Therefore, no new or worsening AEs can be extracted from this note."
ccecd2b9caceb75e156d158ef7513799,1/11/19,"```json
[]
```

**Explanation**: The provided clinical note does not explicitly list any new or worsening adverse events (AEs). It mentions ""abnormal labs and symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AE sheet"" and refers to a ""Free Text Progress Note for updated AEs."" However, no specific AEs are detailed in the text provided. Therefore, no new or worsening AEs can be extracted based on the information given."
ccecd2b9caceb75e156d158ef7513799,1/22/19,"```json
[
  {
    ""AE Term"": ""Rash"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Abdominal pain (worsened from baseline)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
8cef60952b35498cb9fe41077e327d0f,11/26/18,"```json
[
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
8cef60952b35498cb9fe41077e327d0f,12/24/18,"```json
[]
``` 

**Explanation**: The provided clinical note does not mention any new or worsening adverse events (AEs). It primarily discusses the patient's communication with the study team regarding scheduling and does not include any clinical symptoms or adverse events. Therefore, the output is an empty JSON list."
8cef60952b35498cb9fe41077e327d0f,1/8/19,"```json
[]
``` 

**Explanation:**  
The clinical note provided does not describe any new or worsening adverse events (AEs) that emerged after the start of treatment. The note mentions ""itching is much improved,"" which indicates that itching was a baseline symptom and has improved rather than worsened. No other adverse events are described in the text."
8cef60952b35498cb9fe41077e327d0f,1/25/19,"```json
[
  {
    ""AE_Term"": ""Shingles"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Pain"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Burning sensation"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  },
  {
    ""AE_Term"": ""Oozing blisters"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease_Related"": ""Possible"",
      ""Drug_Device_Intervention"": ""Unlikely"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
8cef60952b35498cb9fe41077e327d0f,2/19/19,"Based on the provided clinical note, there is no explicit mention of specific new or worsening adverse events (AEs) in the text. The note states that adverse events were reviewed and summarized, but the actual details of the AEs are not included in the provided text. Therefore, the output will reflect the absence of extractable AE data.

```json
[]
``` 

If additional details about the adverse events are available in another section of the clinical documentation, please provide that information for further extraction."
8cef60952b35498cb9fe41077e327d0f,2/26/19,"Based on the provided clinical note, there is no explicit mention of specific new or worsening adverse events (AEs) or their details (e.g., AE term, grade, attribution). The note only states that ""All AE's and attributions [were] reviewed and approved by the attending physician,"" without listing the actual AEs or their characteristics.

If you have additional clinical notes or documentation that explicitly describe the new or worsening AEs, please provide them, and I can assist further."
8cef60952b35498cb9fe41077e327d0f,3/5/19,"```json
[
  {
    ""AE_Term"": ""Pruritus (Itching)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug/Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unlikely""
    }
  }
]
``` 

### Explanation:
- **Pruritus (Itching)**: The note explicitly mentions that the patient decided not to have the study drug infusion due to itching, which is improving but still unresolved. This suggests that the itching is a new or worsening adverse event after the start of treatment.
- **Grade**: The severity of the itching is not explicitly stated, but since the patient is still debating whether to continue treatment and the symptom is described as ""improving,"" it is reasonable to classify it as Grade 1 (mild).
- **Attribution**:
  - **Disease Related**: Unlikely, as there is no indication that the itching is related to the underlying disease.
  - **Drug/Device Intervention**: Possible, as the patient is on hold from the study drug due to this symptom, suggesting a potential link.
  - **Related to Other**: Unlikely, as no other cause is mentioned in the note.

No other new or worsening adverse events are explicitly described in the provided text."
8cef60952b35498cb9fe41077e327d0f,3/5/19,"```json
[
  {
    ""AE_Term"": ""Pruritus (Itching)"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease_Related"": ""Unlikely"",
      ""Drug_Device_Intervention"": ""Possible"",
      ""Related_to_Other"": ""Unrelated""
    }
  }
]
```"
8cef60952b35498cb9fe41077e327d0f,4/3/19,"```json
[]
```

**Explanation**: The provided clinical note does not mention any new or worsening adverse events. It primarily discusses the patient's decision to skip scheduled clinic visits and wait until the restaging time point. There is no mention of symptoms, adverse events, or their attribution in the text."
8cef60952b35498cb9fe41077e327d0f,4/16/19,"```json
[
  {
    ""AE Term"": ""Itching"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
8cef60952b35498cb9fe41077e327d0f,5/28/19,"```json
[]
```

### Explanation:
The clinical note does not explicitly document any **new or worsening adverse events** (AEs) that emerged after the start of treatment. The note mentions ""itching"" as a symptom, but it is described as ""improving but still unresolved,"" which suggests it is not a new or worsening AE. Additionally, the note states that ""abnormal labs and clinical symptoms noted but none are considered clinically significant/SAE/AESI unless otherwise noted,"" and no specific new or worsening AEs are detailed in the physician or RN notes. Therefore, no AEs meet the criteria for extraction."
8cef60952b35498cb9fe41077e327d0f,7/9/19,"```json
[
  {
    ""AE Term"": ""Pruritus (Itching)"",
    ""Grade"": ""Not specified"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
8cef60952b35498cb9fe41077e327d0f,8/20/19,"```json
[]
```

### Explanation:
- The clinical note explicitly states: ""No new AEs noted at this visit.""
- Therefore, there are no new or worsening adverse events to extract from this note."
8cef60952b35498cb9fe41077e327d0f,9/17/19,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) reported at this visit. The note explicitly states, ""No new AEs noted at this visit."" Additionally, the itching mentioned is described as ""improving but still unresolved,"" which indicates it is not a new or worsening AE. Therefore, the output is an empty JSON list."
8cef60952b35498cb9fe41077e327d0f,10/29/19,"```json
[
  {
    ""AE Term"": ""Pruritus (Itching)"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
8cef60952b35498cb9fe41077e327d0f,12/10/19,"```json
[
  {
    ""AE Term"": ""Pruritus (Itching)"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
8cef60952b35498cb9fe41077e327d0f,1/21/20,"```json
[]
```

**Explanation**: The provided clinical note does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily discusses the patient's missed visit due to an illness at home, but it does not provide specific details about the illness or its attribution to the treatment, disease, or other factors. Therefore, no AEs can be extracted based on the given information."
8cef60952b35498cb9fe41077e327d0f,3/3/20,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that abnormal labs and clinical symptoms were reviewed but none were considered clinically significant, serious adverse events (SAE), or adverse events of special interest (AESI) unless otherwise noted in the physician and RN notes. Additionally, no specific adverse events are described as emerging or worsening after the start of treatment."
880d1b0ab2e5e4946585422e8ce11ac4,8/21/19,"```json
[]
``` 

Explanation: The provided clinical note does not mention any new or worsening adverse events after the start of treatment with M7824. It primarily discusses protocol information, informed consent, and logistical details regarding the patient's treatment and follow-up. No adverse events are documented in this note."
880d1b0ab2e5e4946585422e8ce11ac4,8/29/19,"```json
[]
```

**Explanation**: The provided clinical note does not include specific details about new or worsening adverse events (AEs) that emerged after the start of treatment. It only mentions a ""Week #2 AE Summary"" and that all adverse events were reviewed with Dr. Strauss, but no explicit AEs, grades, or attributions are listed in the text. Therefore, no AEs can be extracted based on the given information."
880d1b0ab2e5e4946585422e8ce11ac4,9/3/19,"```json
[]
``` 

Explanation: The provided clinical note does not explicitly list any new or worsening adverse events (AEs) that emerged after the start of treatment with M7824. It mentions a summary of adverse events reviewed with Dr. Julius Strauss but does not provide specific details about the AEs, their grades, or attribution. Without explicit information, no AEs can be extracted."
880d1b0ab2e5e4946585422e8ce11ac4,9/9/19,"```json
[]
```

**Explanation**: The provided clinical note does not explicitly describe any new or worsening adverse events (AEs) that emerged after the start of treatment. The note primarily discusses the patient's admission for confusion and evaluation of a draining right groin tumor mass, along with baseline findings such as severe hypercalcemia and a brain mass. These symptoms appear to be present before treatment and are not explicitly identified as new or worsening AEs related to the intervention (m7824) or other causes. Therefore, no AEs are extracted based on the provided information."
f089e1b909605b0d39ac54cc18f05758,6/25/19,"Based on the provided clinical note, there are no mentions of new or worsening adverse events (AEs) after the start of treatment. The note primarily discusses protocol documentation and the successful collection of a research blood sample, with no reference to symptoms or adverse events.

Here is the JSON output:

```json
[]
```"
f089e1b909605b0d39ac54cc18f05758,6/25/19,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no new or worsening adverse events (AEs) documented after the start of treatment. All symptoms listed under ""Baseline symptoms/conditions"" are explicitly noted as pre-existing conditions, and no new AEs or worsening of these conditions are described in the text."
f089e1b909605b0d39ac54cc18f05758,6/26/19,"```json
[]
``` 

**Explanation:**  
The provided clinical note does not mention any adverse events (AEs), new or worsening symptoms, or any indication of treatment-related issues. It primarily documents protocol-related information regarding the research sample disposition and does not include any clinical observations or patient-reported outcomes related to adverse events."
f089e1b909605b0d39ac54cc18f05758,6/27/19,"```json
[]
``` 

**Explanation:**  
The clinical note explicitly states, ""No ongoing adverse events noted."" This indicates that there are no new or worsening adverse events to report. Therefore, the output is an empty JSON list."
f089e1b909605b0d39ac54cc18f05758,7/9/19,"```json
[
  {
    ""AE Term"": ""Pruritus"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
f089e1b909605b0d39ac54cc18f05758,7/23/19,"```json
[]
```

**Explanation:**
The clinical note does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs"" and that ""Patient states Pruritus is much improved."" Since no new or worsening AEs are explicitly documented in this note, the output is an empty list."
f089e1b909605b0d39ac54cc18f05758,8/6/19,"```json
[
  {
    ""AE Term"": ""Epistaxis"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
```"
f089e1b909605b0d39ac54cc18f05758,8/20/19,"```json
[
  {
    ""AE Term"": ""Gingival bleeding"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Psoriasis rash"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
f089e1b909605b0d39ac54cc18f05758,9/3/19,"```json
[]
```

### Explanation:
The clinical note explicitly states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs."" Additionally, the patient reports no new episodes of epistaxis or gingival bleeding and mentions improvement in their psoriasis rash. There is no mention of any new or worsening adverse events in the provided text. Therefore, the output is an empty JSON list, as no new or worsening AEs were documented."
f089e1b909605b0d39ac54cc18f05758,9/17/19,"```json
[
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
f089e1b909605b0d39ac54cc18f05758,10/1/19,"```json
[
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Mucosal bleeding"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
f089e1b909605b0d39ac54cc18f05758,10/15/19,"```json
[]
``` 

**Explanation**: Based on the provided clinical note, there are no explicitly documented new or worsening adverse events (AEs) that emerged after the start of treatment. The note mentions ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs."" Additionally, the ongoing anemia and concern for mucosal bleeding are mentioned, but there is no indication that these are new or worsening events attributable to the treatment. Therefore, no AEs are extracted."
f089e1b909605b0d39ac54cc18f05758,10/29/19,"```json
[]
``` 

**Explanation**:  
The clinical note provided does not explicitly document any new or worsening adverse events (AEs) that emerged after the start of treatment. The note mentions ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs."" However, no specific AEs are detailed in the text. Additionally, the ongoing anemia and concern for mucosal bleeding are mentioned, but there is no indication that these are new or worsening since the start of treatment. Therefore, no AEs can be extracted based on the provided information."
f089e1b909605b0d39ac54cc18f05758,11/12/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly documented. The note mentions ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs."" Additionally, the ongoing anemia and mucosal bleeding are described as reasons for holding treatment, but there is no indication that these are new or worsening adverse events attributable to the treatment (m7824). Therefore, no adverse events meet the criteria for extraction."
f089e1b909605b0d39ac54cc18f05758,11/13/19,"```json
[]
``` 

Explanation: The provided clinical note does not mention any new or worsening adverse events. It primarily contains protocol-related information, consent details, and electronic signatures. No adverse events are described in the text."
f089e1b909605b0d39ac54cc18f05758,11/26/19,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no mentions of new or worsening adverse events. The note primarily discusses the patient's missed visit due to a dental root canal and holiday travel issues, which are not adverse events related to the treatment or protocol."
f089e1b909605b0d39ac54cc18f05758,12/10/19,"Based on the provided clinical note, there is no explicit mention of new or worsening adverse events (AEs) that emerged after the start of treatment. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs."" Since no specific AEs are described in the text, the output will reflect the absence of extractable AEs.

```json
[]
```"
f089e1b909605b0d39ac54cc18f05758,12/24/19,"```json
[]
``` 

Explanation: The provided clinical note does not mention any new or worsening adverse events. It primarily discusses the patient's decision to miss a scheduled protocol visit due to holiday plans with family. No symptoms or adverse events are described in the text."
f089e1b909605b0d39ac54cc18f05758,1/7/20,"```json
[]
``` 

Explanation: The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. It states that abnormal labs and/or symptoms were noted but none were clinically significant unless otherwise documented in physician-reviewed AEs. Additionally, there is no specific mention of new or worsening symptoms or adverse events attributed to the disease, drug/device intervention (m7824), or other causes. Therefore, no AEs can be extracted based on the provided information."
f089e1b909605b0d39ac54cc18f05758,1/22/20,"```json
[]
```

**Explanation:**
The clinical note provided does not document any new or worsening adverse events (AEs) that emerged after the start of treatment. The note mentions ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs,"" and no specific AEs are described in the text. Additionally, the procedure (TAVR aortic valve replacement) is mentioned as having gone well, with no adverse events reported in relation to the procedure or the study intervention (m7824). Therefore, no AEs are extracted."
f089e1b909605b0d39ac54cc18f05758,2/4/20,"```json
[]
``` 

### Explanation:
After reviewing the provided clinical note, there are no new or worsening adverse events (AEs) documented. The patient is reported to be ""doing well"" and denies any signs or symptoms of active bleeding. The nodules at the groin area (catheter insertion site) were evaluated via ultrasound with no abnormal findings reported. Psoriasis is noted to be well-controlled with medication, and no new or worsening symptoms are described. Therefore, no AEs meet the criteria for extraction."
f089e1b909605b0d39ac54cc18f05758,2/18/20,"```json
[
  {
    ""AE Term"": ""Pancytopenia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 2,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Dizziness"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention?"": ""Unlikely"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
f089e1b909605b0d39ac54cc18f05758,3/3/20,"```json
[
  {
    ""AE Term"": ""Pancytopenia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": 3,
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Probable"",
      ""Related to Other?"": ""Unlikely""
    }
  },
  {
    ""AE Term"": ""Dizziness"",
    ""Grade"": 1,
    ""Attribution"": {
      ""Disease Related?"": ""Unlikely"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unlikely""
    }
  }
]
```"
f089e1b909605b0d39ac54cc18f05758,3/31/20,"```json
[
  {
    ""AE Term"": ""Dizziness"",
    ""Grade"": ""1"",
    ""Attribution"": {
      ""Disease Related?"": ""Possible"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Unlikely"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Pancytopenia"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  },
  {
    ""AE Term"": ""Anemia"",
    ""Grade"": ""2"",
    ""Attribution"": {
      ""Disease Related?"": ""Probable"",
      ""Drug/Device Intervention? (Intervention: m7824)"": ""Possible"",
      ""Related to Other?"": ""Unrelated""
    }
  }
]
``` 

### Explanation:
1. **Dizziness**: This is a new symptom mentioned in the note (""recent dizziness episodes""). It is mapped to CTCAE terminology and graded as mild (Grade 1). Attribution is assessed based on the context provided.
2. **Pancytopenia**: This condition is noted as ongoing and treatment is being held due to it. It is assumed to have worsened after treatment initiation, as it is significant enough to impact treatment decisions. Graded as moderate (Grade 2).
3. **Anemia**: Similarly, anemia is noted as a reason for iron infusion and treatment hold. It is assumed to have worsened after treatment initiation. Graded as moderate (Grade 2).

### Notes:
- Only new or worsening AEs after treatment initiation are included.
- Attribution is based on the available context, with assumptions made conservatively.
- Grades are assigned based on CTCAE guidelines and clinical interpretation of severity."
f089e1b909605b0d39ac54cc18f05758,4/17/20,"```json
[]
```

**Explanation**: The clinical note explicitly states that the patient ""continues to feel well"" and has ""no new or concerning symptoms to report."" Therefore, there are no new or worsening adverse events (AEs) to extract from this note."
f089e1b909605b0d39ac54cc18f05758,4/29/20,"```json
[]
```

**Explanation**: The clinical note provided does not explicitly describe any new or worsening adverse events (AEs) that emerged after the start of treatment. It mentions ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs."" However, no specific AEs are detailed in the text. Therefore, no new or worsening AEs can be extracted based on the provided information."
f089e1b909605b0d39ac54cc18f05758,5/11/20,"```json
[]
``` 

Explanation: The provided clinical note does not mention any new or worsening adverse events. It primarily discusses protocol documentation, the patient's awareness of the plan, and the deferred visit due to COVID-19 concerns. No adverse events are described in the text."
f089e1b909605b0d39ac54cc18f05758,6/9/20,"```json
[]
``` 

Explanation: Based on the provided clinical note, there are no new or worsening adverse events explicitly mentioned. The note states that ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician-reviewed AEs."" Since no specific adverse events are described as new or worsening, and no CTCAE terms are provided, the output is an empty JSON list."
f089e1b909605b0d39ac54cc18f05758,9/15/20,"```json
[]
``` 

**Explanation:**  
The clinical note provided does not explicitly mention any new or worsening adverse events (AEs) that emerged after the start of treatment. The note states ""abnormal labs and/or symptoms noted but none clinically significant unless otherwise noted in physician/prescriber notes."" However, no specific AEs are described in the text. Therefore, the output is an empty JSON list."